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Szanowni CzytelniCy „Forum DermatologiCum”,
Drogie KoleżanKi i KoleDzy,
z wielką przyjemnością możemy Państwu zaprezentować streszczenia i tematykę prac prezentowanych podczas tego-
rocznej, IV już edycji Ogólnopolskiej Konferencji Naukowej organizowanej przez Studenckie Koło Naukowe Kliniki Derma-
tologicznej Warszawskiego Uniwersytetu Medycznego, która odbędzie się 3 marca w Warszawie na terenie naszej kliniki, 
przy ul. Koszykowej 82a. 
Możliwość dotarcia do tak szerokiego odbiorcy oraz opublikowanie streszczeń w „Forum Dermatologicum”  było możliwe 
dzięki wydawnictwu Via Medica. Pragniemy szczerze podziękować za ten gest i wyjście naprzeciw pragnieniom przyszłych 
i młodych lekarzy zainteresowanych odkrywaniem dermatologii, piękna medycyny i jej interdyscyplinarności. 
Konferencja „Interdyscyplinarne Aspekty Chorób Skóry i Błon Śluzowych”, powstała w celu wymiany wzajemnych doświad-
czeń dotyczących objawów dermatologicznych w rożnych dziedzinach medycyny. Ku naszej radości konferencja cieszy się 
coraz większym zainteresowaniem, co świadczy o wspólnej potrzebie jej współtworzenia przez studentów i lekarzy różnych 
specjalności. Otrzymaliśmy ponad sto prac z różnych klinik i ośrodków naukowych z całej Polski. Ten fakt wskazuje na duże 
zainteresowanie zagadnieniami związanymi z dermatologią oraz prawidłową interpretacją zmian skórnych w codziennej 
praktyce lekarzy wielu specjalności.
Nie budzi wątpliwości, że obecna medycyna opiera się na specjalistycznej współpracy interdyscyplinarnej. Naukowcy 
przekuwają swoje odkrycia na grunt medycyny klinicznej, a klinicyści poszukują odpowiedzi na swoje pytania w badaniach 
naukowych. Wzajemna wymiana doświadczeń i poszukiwanie odpowiedzi na kolejne pytania tworzą wzajemną płaszczyznę 
porozumienia i rozwoju nauk biologicznych i medycznych. To właśnie dzięki ludziom młodym, dociekliwym, zmotywowanym 
i ciekawym odkryć, kształtuje się medycyna teraźniejszości, a rodzi przyszłości. Wyrażamy nadzieję, że taką możliwość daje 
między innymi nasza konferencja o zasięgu interdyscyplinarnym i ogólnopolskim, a przynajmniej takie jest jej zamierzenie.
Naszą konferencję patronatem objęli najznamienitsi lekarze z Warszawskiego Uniwersytetu Medycznego, Polskiego 
Towarzystwa Dermatologicznego i Izb Lekarskich, a współtworzą lekarze z całej Polski, co bardzo nas cieszy i motywuje do 
dalszego działania. 
W imieniu organizatorów, studentów i lekarzy, serdecznie zapraszam do zaszczycenia nas swoją obecnością 3 marca 
w naszej Klinice Dermatologicznej w Warszawie lub zapoznania się z tematyką poruszanych zagadnień na stronach „Forum 
Dermatologicum”. 
Wyrażamy nadzieję, że tegoroczne zagadnienia zapoczątkują inspirujące dyskusje, zrodzą nowe pomysły i zaowocują 
współpracą na przyszłych interdyscyplinarnych konferencjach naukowych.  
Z wyrazami szacunku
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ORIGINAL RESEARCH — ORAL SESSION
Sodium butyrate — a new therapeutic Strategy for 
pSoriaSiS? 
Alicja Krejner
Studenckie Koło Naukowe HESA przy Katedrze i Zakładzie Histologii 
i Embriologii, Warszawski Uniwersytet Medyczny
trustee of the paper: Agatha Schwarz, Thomas Schwarz
introduction: Recently it has been shown that butyrate, a bacterial 
product from the fermentation of fiber in the colon, is involved in pro-
tection against colonic inflammation. GPR109A/HCA2 and GPR43 are 
the best-known receptors for butyrate. The signaling of both promotes 
anti-inflammatory properties in colonic macrophages and dendritic 
cells and enables them to induce differentiation of IL-10 producing 
regulatory T cells (Treg). Skin autoimmune and chronic inflammatory 
diseases e.g. psoriasis are driven by dysregulated Treg responses. Since 
stimulation of GPRs is necessary for homeostasis in the gut and their 
deficiency enhances susceptibility to colitis, we asked whether a similar 
pattern can be found in psoriasis.
aim of the study: To compare the expression of GPR109A/HCA2 and 
GPR43 and its induction upon butyrate treatment in the healthy and 
psoriatic skin.
materials and methods: Biopsies from the lesional and non-lesional 
skin of 6 psoriatic patients and 6 healthy controls were analyzed for the 
expression of both receptors using immunofluorescence microscopy. 
Then biopsies from psoriatic and healthy skin were stimulated with 
sodium butyrate for 24 hours or left untreated. Afterward, immunoflu-
orescence analysis was performed.
results: The expression of GPR109A/HCA2 and GPR43 was significantly 
reduced in lesional skin in comparison to healthy control skin. The 
expression of both receptors in the non-lesional psoriatic skin was also 
decreased but to a lesser extent. Immunofluorescence analysis revealed 
a significant upregulation of both GPRs upon butyrate treatment.
Conclusions: The role of sodium butyrate as an agonist of GPRs and 
potential inducer of Treg in inflammatory skin diseases may allow the 
development of new therapeutic strategies for psoriasis.
mcr ligandS are potential pSoriaSiS enhancerS
Paweł Rykowski, Radosław Pietrzak, Anna Pasierb
Studenckie Koło Naukowe przy Katedrze i Klinice Dermatologicznej, 
Warszawski Uniwersytet Medyczny
trustee of the paper: Joanna Czuwara, Małgorzata Stakun
introduction: Physiology of skin and immune system seems to be 
tightly connected be only fairly discovered, especially in the appe-
arance of high-end analysis modalities. Last updates suggest role of 
melanocortin receptors (MCR) in crosstalk between keratinocytes and 
macrophages. Macrophages are confirmed instigators of immune re-
sponse in psoriasis. MCR ligands may act as transducers of signal from 
skin to hypophysis and vice versa.
aim of the study: We wanted to investigate the possible relation be-
tween psoriasis severity and plasma concentration of two main MCR 
agonist (Agouti Related Protein AGRP, alpha Melanocyte-Stimulating 
Hormones alphaMSH).
materials and methods: In these cross-sectional study group, 44 pa-
tients were included. Patients were admitted to our clinic due to pso-
riasis exacerbation and examined after 24h rest and standard diet. 
Demographical and biometric information were collected through stan-
dardized Case Report Form. Plasma samples were analyzed using EIA.
results: During performing EIA test four samples act abnormally both 
in AGRP and MSH test. We didn’t observe statistically significant cor-
relation between psoriasis severity. In study group power of Pearson 
correlation r = 0.45 was approximated for 0.9. Four patients AGRP levels 
were significantly higher with MSH normal levels, which was analyzed 
in case series fashion.
Conclusions: There is no strong association between MCR ligands 
and psoriasis severity in general group. There is weak evidence AGRP 
concentration change throughout course of psoriasis, which has to be 
challenged in a longitudinal study.
iS tHe imPaireD BalanCe in tHe HPa axiS tHe Clue oF 
PSoriaSiS PatHogeneSiS? 
Radosław Pietrzak, Paweł Rykowski, Anna Pasierb
Studenckie Koło Naukowe przy Katedrze i Klinice Dermatologicznej, 
Warszawski Uniwersytet Medyczny
trustee of the paper: Joanna Czuwara, Małgorzata Stakun
introduction: The association of endocrine system, especially the hy-
pothalamic-pituitary-adrenal (HPA) axis with psoriasis is nowadays the 
topic of research. The discovery of the skin analog of HPA axis led us 
to understand the psoriatic skin response to stress. In 2017 Hannen et 
al. showed the steroidogenesis is impaired in psoriasis lesion and non-
-lesional skin. Whether this is a starting disturbance or the effect of the 
global HPA axis dysfunction is not known.
aim of the study: The aim was to test whether severity of psoriasis is 
related to ACTH/cortisol index, as a marker of HPA axis function. 
materials and methods: The study consisted of 40 patients with pso-
riasis (12 women/28 men) after written informed consent. Severity of 
disease was assessed by PASI, BSA and DLQI. The concentrations of 
serum ACTH, cortisol and other basic laboratory tests were measured. 
Body composition parameters were measured.
results: The prevalence of mild psoriasis was in (PASI < 12) 6 cases, 
moderate (12 < PASI < 30) 22 cases and severe (PASI > 30) 12. We found 
the positive correlation between ACTH/COR with PASI (p =  0.0487), and 
negative correlation with Age (p = 0.0254). There was no significant 
correlation between the ACTH/COR and bioimpedance results.
Conclusions: Our analysis shows the relation between the balance in 
HPA axis and the PASI, which indicates that not only skin-derived HPA 
axis is affected. Further natural step in appearance of these evidence 
are longitudinal studies in risk group of psoriasis, revealing if changes 
are primary or secondary.
obeSity and pSoriaSiS: are adipokineS the link?
Anna Pasierb, Radosław Pietrzak, Paweł Rykowski
Studenckie Koło Naukowe przy Katedrze i Klinice Dermatologicznej, 
Warszawski Uniwersytet Medyczny
trustee of the paper: Joanna Czuwara, Małgorzata Stakun
introduction: Adipose tissue is an active endocrine organ which regu-
lates multiple metabolic pathways via self-produced adipokines. These 
molecules are suspected for pathogenesis of metabolic syndrome and 
cardiovascular diseases. Co-occurrence of these two with psoriasis 
rise a question how they interact and whether adipokines may be 
a connecting link. 
aim of the study: The aim of the study was to assess adipokines levels 
and metabolic parameters in psoriatic patients.
materials and methods: The study consisted of 43 patients with pso-
riasis (11 women/32 men) after written informed consent. Psoriasis 
severity was assessed by DLQI, PASI and BSA score. The concentrations 
of serum: chemerin, visfatin, adiponectin, leptin, resistin and RBP-4, 
total cholesterol (TChol), high-density lipoprotein (HDL), low-density 
lipoprotein (LDL) and hsCRP protein were measured. Body composition 
parameters (BMI, WHR) were measured.
results: The prevalence of mild psoriasis was (PASI < 12) 13 cases, mo-
derate (12 < PASI < 30) 24 cases and severe (PASI > 30) 6. The incidence 
of overweight was 31.8% and obesity 45.5%. There was no correlation 
between PASI, BSA a serum adipokines levels. We found a significant 
correlation between PASI and hsCRP (p = 0.024); chemerin and WHR 
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(p = 0.045), hsCRP (p < 0.0001), TChol (p = 0.010), HDL (p = 0.001), 
LDL (p = 0.020). TChol correlated with BSA score (p = 0.016) and with 
resistin (p = 0.040). 
Conclusions: Our study did not directly show the relationship between 
adipokines and psoriasis. But due to limitations of our study (most 
patients obese or overweight), we cannot say that this interaction does 
not exist, as epidemiologic data underline the interplay. Further studies 
are needed to deeply understand the role of adipokines in psoriasis.
influence of bmi on Severity of acne leSionS 
Bartłomiej Kurczab, Katarzyna Krzyworzeka, Katarzyna Fiszer 
Koło Dermatologii przy Katedrze i Klinice Dermatologii, Śląski Uniwersytet 
Medyczny w Katowicach
trustee of the paper: Beata Bergler-Czop
introduction: Acne tends to be chronic, refractory to treatment and 
associated with psychosocial problems and depressive disorders. So 
far scientific literature has reported that higher BMI is a risk factor for 
more severe acne.
aim of the study: The aim of this study was to investigate the influence 
of BMI on the severity of acne lesions in men and women between 
17 and 31 years of age.
materials and methods: 1695 women and 484 men between 17 and 
31 years of age with varied intensification of acne lesions were enrolled 
in this study. The data was collected through anonymous online ques-
tionnaire. The participants were shown 12 photos from The Leeds Revised 
Acne Grading System, picturing different degrees of acne severity on the 
face. The participants were supposed to choose one photo picturing 
current condition of their complexion.
results: Spearman’s rank correlation coefficient revealed that BMI is 
negatively correlated with the severity of acne lesions in women at the 
age exceeding 18 years old (R =  -0.066; p =  0.0101). On the other hand, 
Kendall’s rank correlation coefficient proved that among women at the 
age of 17 the correlation is positive (Τ = 0.101; p = 0.0327). In men we 
did not notice any statistically significant connection between BMI, age 
and severity of the acne lesions.
Conclusions: Initial findings indicate that higher BMI is protective factor 
against acne in mature women. On the other hand, in women younger 
than 18, higher BMI is a significant risk factor for more severe acne 
lesions.
dermatological SignS of Sexual function diSorderS 
in women with the functional hyperandrogenic 
Syndrome
Anna Kępczyńska-Nyk, Urszula Ambroziak, Anna Nowak,  
Alina Kuryłowicz, Tomasz Bednarczuk
ENDOCRINUS, Studenckie Endokrynologiczne Koło Naukowe, Warszawski 
Uniwersytet Medyczny
trustee of the paper: Urszula Ambroziak
introduction: The functional hyperandrogenic syndrome is one of 
the most common disorders found in patients of gynecological en-
docrinology, in which patients suffer from excessive secretion of an-
drogens resulting in masculinization, defeminization and metabolic 
disorders. Moreover, it includes disorders of sexual function, but so far 
there has been no thorough research about its correlation to the clinical 
picture and laboratory findings.
aim of the study: The aim of the study was to compare sexual function 
using female sexual function index (FSFI) questionnaire in women with 
the functional hyperandrogenic syndrome (FHS): polycystic ovary syn-
drome (PCOS), congenital adrenal hyperplasia (CAH) considering clinical 
versus laboratory findings, with the sexual function of healthy controls.
materials and methods: The study included 73 women aged 
18−40 years with functional hyperandrogenic syndrome: 56 with PCOS, 
17 with congenital adrenal hyperplasia and 20 healthy controls. All par-
ticipants completed Female Sexual Function Index (FSFI) questionnaire 
assessing sexual function in the domains of desire, arousal, lubrication, 
orgasm, satisfaction and pain. Additionally, clinical laboratory asses-
sment was performed in all patients.
results: Study results indicate that patients with PCOS show to have 
the highest quality of sexual functions in comparison to women 
suffering from CAH and control group. Authors found that sexual 
function quality index is highly correlated with the levels of specific 
androgens.
Conclusions: Dermatological signs of the functional hyperandrogenic 
syndrome are in close correlation with sexual function. It is essential 
for a physician to recognize these signs and direct patients not only to 
a dermatologist, endocrinologist but also to a sexologist.
evaluation of mmp-1, mmp-2 and timp-1 concentrationS 
in the courSe of ad
Magdalena Basałygo, Joanna Śliwińska, Dominika Ragin,  
Magdalena Żbikowska-Gotz, Kinga Lis, Ewa Socha, Zbigniew Bartuzi, 
Barbara Zegarska
Collegium Medicum im. Ludwika Rydygiera w Bydgoszczy, Uniwersytet 
Mikołaja Kopernika w Toruniu
trustee of the paper: Barbara Zegarska
introduction: MMPs are important elements conditioning the integrity 
of skin cells, and determination of the speed of matrix components 
synthesis and the speed of its components degradation is crucial for the 
correct condition of epidermal barrier in the course of atopic dermatitis.
aim of the study: Evaluation of MMP-1, MMP-2 and TIMP-1 concen-
trations taking into consideration parameters of epidermal barrier in 
the course of AD. 
materials and methods: The study involved a group of 43 people 
suffering from AD and a control group of 22 people. The test was 
carried out by marking the TEWL value using the Tewameter TM 
300 and by marking the skin’s hydration level using the Corneom-
eter CM 825. The concentration measurement of MMP-1, MMP-2, 
TIMP-1 in blood serum was carried out using the enzyme-linked 
immunosorbent assay.
results: Average concentration values of MMP-1 in blood serum 
were 1278.77 ± 666.71 SD [pg/ml] in patients suffering from AD and 
911.51 ± 662.7 SD in the control group. In the examined group an average 
MMP-2 concentration was 1312.58 ± 3901.15 SD, and 85.09 ± 202.78 SD 
in the control group. TIMP-1 concentration was higher in patients suf-
fering from AD and its level was 568.88 ± 462.19 SD. Patients suffering 
from AD obtained the TEWL statistically significantly lower in the area 
of changed skin and 2 cm away from the atopic changes when the TIMP 
concentration is higher than MMP-1 concentration (Mann-Whitney test, 
Z = 1.624, p < 0.05).
Conclusions: Predominance of TIMP-1 over MMP-1 reduces TEWL and 
maintains correct hydration of the epidermis. 
Quality of life and expectationS of parentS of 
children with atopic dermatitiS — preliminary reSultS
Paulina Lewandowska, Alicja Ograczyk-Piotrowska, Andrzej Kaszuba, 
Anna Zalewska-Janowska 
Studenckie Koło Naukowe Psychodermatologii, Uniwersytet Medyczny w Łodzi
trustee of the paper: Anna Zalewska-Janowska
introduction: Atopic dermatitis (AD) is a common chronic skin disease in 
children. It has a huge impact on the quality of life of patients and their 
families, particularly due to its chronic and relapsing history.
aim of the study: To evaluate the impact of AD on family quality of life 
and to determine major problems in therapy and parents’ expectations 
of doctors.
materials and methods: The study included 30 children (divided into 
two groups: 0−4 and 4−18 years old) with AD. The patients and their par-
ents completed Dermatitis Family Impact Questionnaire, Children’s Der-
matology Life Quality Index or Infant’s Dermatitis Quality of Life Index 
and specially created Preliminary Survey of Parents of Children with 
Atopic Dermatitis Expectations.
results: The authors observed that there was a statistically significant 
correlation between the infants’ quality of life and family functioning 
(r = 0.744) as well as between the children’s quality of life and family 
functioning (r = 0.565). According to the survey, 47% of the parents 
were not satisfied with the amount of information about the disease 
that they received from doctors. The most frequent problems in therapy 
were costs, dirty clothing and time-consuming treatment. For almost 
two-thirds of patients and parents the only source of knowledge about 
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AD was their doctor. However, 60% of them found the information on 
the Internet.
Conclusions: To conclude, AD has a great impact on sufferers and their 
family life. There is a necessity to provide patients’ parents with sufficient 
amount of information about the disease via qualified personnel.
phototoxic and photoallergic Skin reactionS  
— reSultS of a Single-center retroSpective Study
Joanna Zozula, Piotr Celmer, Michalina Derbich
Studenckie Koło Naukowe przy Katedrze i Klinice Dermatologii, Warszawski 
Uniwersytet Medyczny
trustee of the paper: Magdalena Misiak-Gałązka
introduction: Phototoxic and photoallergic skin reactions are classified 
as exogenous photodermatoses, induced by an interaction between 
topical or systemic sensitizer and exposure to ultraviolet radiation (UVR). 
Drugs, plants, dyes, fragrances or even sunscreen chemicals can act as 
photosensitizers. Among all patients with photosensitivity, phototoxic 
eczema occurs in 8% and photoallergic eczema in 7%.
aim of the study: The aim of the study was to determine the most 
common photosensitizers.
materials and methods: The study is based on a retrospective review 
from 2009 to 2013 of data extracted from the medical records of 
Department of Dermatology, Medical University of Warsaw. A total 
of 66 patients suspected of photosensitivity underwent photopatch 
tests with 38 photosensitizers. The reactions were scored using the 
International Contact Dermatitis Research Group visual scoring system. 
The mean age of patients was 50.40 of 66 patients were women. UVB 
and UVA phototests were performed as well.
results: 41 out of 66 patients (62.12%) presented hypersensitivity to 
UVB radiation, and 6 (9.09%) presented hypersensitivity to UVA radia-
tion. Positive photopatch test reactions to one or more chemicals were 
detected in 49 patients (74%). The most common photosensitizers were 
coal tar — 31 patients (63%), peru balsam — 13 patients (26.5%) and 
nickel — 12 patients (24.5%).
Conclusions: Photopatch testing remains an integral part and gold 
standard for the work-up of the photosensitive patients.
review of pharmacological interventionS  
in Self-inflicted Skin diSeaSeS
Adrianna D. Opalska, Wioletta M. Barańska-Rybak, Roman J. Nowicki 
Klinika Dermatologii, Wenerologii i Alergologii, Gdański Uniwersytet 
Medyczny
trustee of the paper: Wioletta Barańska-Rybak 
introduction: Self-inflicted skin diseases (SISD) are the group of psycho-
dermatoses belonging to the group of simulated disorders. Skin lesions 
are the result of a patient’s activity aimed at getting someone’s attention 
or care. During the diagnostic process patients visit many physicians of 
various specialties, perform numerous diagnostic tests, and apply many 
medications, mostly unsuccessfully.
aim of the study: Presentation of pharmacological interventions used 
in patients with SISD.
materials and methods: During a one-year period (2016−2017) pa-
tients diagnosed as SISD, seen in the Department of Dermatology, 
Venereology and Allergology Medical University of Gdańsk, were record-
ed. Each patient was given a detailed interview about the diagnostic 
procedures and drugs used so far.
results: Eleven patients were selected: 9 women and 3 men, mean age 
was 51 years. 100% patient was treated with local antibiotics and 45% 
were used oral antibiotics. In 82% patients local glicocortycosteroids 
were used. 18% were treated with arechin. 1 patient used Wilkinson 
ointment. Antifungal local drugs were used in 33% patients. In 100% 
of patients, no clinical improvement was observed during any of the 
treatments. Psychological support was offered to 100% of the patients 
and was accepted by 45%.
Conclusions: Each of the patients with SISD before the diagnosis is 
treated with many pharmaceuticals. After establishing the diagnosis, 
the patient’s cooperation with the dermatologist, psychiatrist and psy-
chotherapist is necessary in the therapeutic process.
tumor-aSSociated antigenS in SyStemic ScleroSiS 
Filip Fijołek, Barbara Pasierb
Studenckie Koło Naukowe przy Katedrze i Klinice Dermatologii, Wenerologii 
i Dermatologii Dziecięcej, Uniwersytet Medyczny w Lublinie
trustee of the paper: Dorota Krasowska, Agnieszka Gerkowicz
introduction: Tumor-associated antigens are a group of proteins usu-
ally restricted to tumor cells although they may also be expressed on 
normal cells as well as on inflammatory cells. Recent data indicate that 
the production of these antigens may be increased in autoimmune 
diseases such as systemic sclerosis.
aim of the study: Retrospective analysis of patients with systemic 
sclerosis in whom at least one tumor-associated antigen was assessed.
materials and methods: We reviewed clinical files of 51 patients with 
systemic sclerosis both localized and diffuse (43 [84.31%] and 8 [15.69%], 
respectively) hospitalized in 2005−2017. Median age was 66 (range: 
37−88). In all patients, at least one tumor-associated antigen, including 
CA 125, HE4, CA 19-9, CEA, CA 15-3, AFP and CA 72-4, was assessed.
results: The most commonly assessed tumor-associated antigens were: CA 
125, CA 15-3, CEA — assessed in 48 (94.12%) patients. CA 19-9, AFP, HE4, CA 
72-4 were evaluated respectively in 47 (92.16%), 38 (74.51%), 29 (56.86%), 
and 10 (19.61%) patients. 27 patients (52.94%) had increased levels of 
minimum one antigen — 21 (77.78%) with localized and 6 (22.22%) with 
diffuse scleroderma. In all cases antigen levels were assessed to monitor the 
immunosuppressive therapy and to exclude malignant process.
Conclusions: Our study demonstrated that levels of tumor-associated 
antigens were increased in some patients with systemic sclerosis. Moni-
toring of tumor-associated antigens in systemic sclerosis enhances the 
safety of long immunosuppressive therapy and enables fast diagnosis 
of malignant condition. Further research could determine the relevance 
of tumor-associated antigens in systemic sclerosis.
the role of dermoScopy in the diagnoSiS of lichen 
ScleroSuS and lichen planuS of the vulva
Katarzyna Kornicz, Olga Grunt
Studenckie Koło Naukowe przy Katedrze i Klinice Dermatologicznej, 
Warszawski Uniwersytet Medyczny
trustee of the paper: Marek Opala
introduction: Numerous skin disorders can be located in the region of 
the female genital organs. It is necessary to make the correct diagnosis 
and to choose a proper treatment. Lichen sclerosus is skin disorder with 
symptoms like pruritic, burnings, soreness, dyspareunia and signs like 
hyperkeratosis, erosions, fissures. Lichen planus occur with very similar 
symptoms and that’s why clinical lesion is not always characteristic for 
just one of this skin disorder.
aim of the study: The aim of the study is to explore the role of dermos-
copy in identification of lichen sclerosus and lichen planus of the vulva.
materials and methods: Study analyzed 10 clinical cases with histo-
pathologically confirmed lichen sclerosus or lichen planus of the vulva. 
Evaluation of specific patterns was performed with the use of images 
from the dermoscopy assay.
results: The most common dermoscopy findings of lichen sclerosus 
are: white to yellowish structureless areas, ice-like patches, white dots, 
irregular vessels. The most common dermoscopy findings of lichen 
planus are white scaling patches, reddish areas, irregular vessels.
Conclusions: Dermoscopy may serve as a rapid non-invasive method for 
the preliminary diagnosis of lichen sclerosus and lichen planus of the vulva.
clinical profile of 45 patientS with vulvar lichen 
ScleroSuS
Alicja Szatko, Kinga Grzelak
Studenckie Koło Naukowe przy SKN przy II Katedrze i Klinice Położnictwa 
i Ginekologii, Warszawski Uniwersytet Medyczny
trustee of the paper: Monika Kalinowska, Agnieszka Dobrowolska-
-Redo, Ewa Romejko-Wolniewicz
introduction: Lichen sclerosus (LS) is a chronic, immune-mediated 
dermatosis, occurring mainly in women, with a predilection for the 
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anogenital region. Due to the lack of clinical data, there is a necessity 
to study etiology, pathogenesis and optimal therapy of LS.
aim of the study: The aim of the study was to analyze clinical features 
and therapy of vulvar lichen sclerosus.
materials and methods: In this retrospective study medical records 
of 45 women were analyzed. The study group included patients with 
biopsy-proven vulvar lichen sclerosus who were admitted to tertiary 
referral hospital in Warsaw (Poland) between 2014 and 2017. We have 
analyzed the data concerning patients’ symptoms, potential risk factors 
and current therapy.
results: The mean age of the patients was 57 years old (SD = 14). 
The proportion of premenopausal to postmenopausal patients was 
26.2% to 73.8% (11 to 31). The chief complaint was vulvar pruritus 
(n = 35, 83.3%). The lesions were most frequently localized on the 
labia maiora (n = 16, 35.6%) and the frenulum of labia minora (n = 10, 
22.2%). No statistically important differences were found between 
premenopausal and postmenopausal women concerning the dominant 
symptom (p = 0.381) and the main localization of lesions (p = 0.465). 
The majority of the patients (n = 32) were treated with topical steroids, 
including hydrocortisone (n = 21, 52.5%), clobetasol (n = 21, 52.5%) 
and betamethasone (n = 5, 12.8%) and all treated patients reached 
good clinical response.
Conclusions: Whereas vulvar pruritus remains the most common 
symptom of vulvar lichen sclerosus, the dominant localization of the 
lesions cannot be easily determined. Topical corticosteroids are a bene-
ficial treatment for LS. However, further research is needed.
inflammatory Skin changeS of the forehead  
— retroSpective analySiS
Anna Czaplicka, Aleksandra Maria Soplińska
Studenckie Koło Naukowe przy Katedrze i Klinice Dermatologicznej, 
Warszawski Uniwersytet Medyczny
trustee of the paper: Magdalena Misiak-Gałązka, Joanna Czuwara
introduction: The most common skin changes on the face are skin 
neoplasms. However, many inflammatory dermatoses may also occur 
on face, particularly on the forehead.
aim of the study: The aim of the study was to assess the frequency 
of non-cancerous skin changes biopsied from the forehead. To our 
knowledge, no previous studies in this field have been reported.
materials and methods: Records from biopsies taken in our depart-
ment in years 2010−2016 were analyzed. The following information 
were incorporated: age of patients, sex, preliminary diagnosis, con-
comitant skin changes, duration of disease and histopathological 
diagnosis. Inclusion criteria were: biopsies taken from the frontal 
area and final diagnosis of inflammatory lesion. Biopsies from skin 
cancer were excluded.
results: Amidst 440 biopsies obtained from the forehead, only 
44 met the criteria (10%). 50% of the patients constitute women. 
Mean age of the group was 61.92 years. The most frequent prelim-
inary diagnosis was sarcoidosis. 7 patients presented concomitant 
skin changes in other location. Mean disease duration time was 
1.18 year. The most frequent histopathological findings were in-
verted follicular keratosis (26.67%), acne rosacea (8.89%), atheroma 
(6.67%), granuloma faciale (6.67%), lupus erythematosus (6.67%) 
and sarcoidosis (6.67%).
Conclusions: There are many different inflammatory diseases 
on the face, forehead in particular. They can be purely dermal, 
follicular or dermo-epidermal as it is in lupus erythematosus. Der-
matopathologist after excluding skin malignancy should take into 
account several dermatoses. The most typical one such as atopic 
dermatitis, seborrheic dermatitis are not biopsied as a rule by 
dermatologists.
intratumor genetic heterogeneity in primary 
cutaneouS melanoma — analySiS of the variability of 
the moSt common mutationS
Agnieszka A. Koppolu, Wiktor Paskal, Tomasz M. Grzywa,  
Małgorzata Rydzanicz, Jarosław Wejman, Kinga Szczepaniak,  
Kacper Pełka, Rafał Płoski, Paweł K. Włodarski
HESA, Studenckie Koło Naukowe przy Katedrze i Zakładzie Histologii 
i Embriologii,  Warszawski Uniwersytet Medyczny
trustee of the paper: Paweł Włodarski
introduction: Melanoma tumors are the most heterogeneous of all can-
cer. Tumor heterogeneity results in difficulties in diagnosis and is a fre-
quent cause of failure in treatment. Novel techniques enable accurate 
examination of the tumor cells, taking into account their heterogeneity.
aim of the study: To study the somatic variation among highly and low 
proliferating compartments of melanoma tumors.
materials and methods: 10 archival FFPE samples of primary cutaneous 
melanoma were stained with Ki-67 antibody. Highly and low prolifera-
ting compartments were dissected using Laser Capture Microdissection. 
DNA was isolated and analyzed quantitatively and qualitatively. Using 
NEB Next Direct Cancer HotSpot Panel libraries were prepared.
results: Sufficient amount of material for amplicon-based NGS analy-
sis was obtained. Preliminary analysis showed significant differences 
between highly and low proliferating compartments. Mutations which 
extended in different percentage in both compartments (i.e. mutation in 
KDR, NPM1, FLT3, TP53) as well as mutations which were presented just 
in one compartment (i.e. BRAF, CDKN2A, ERBB4, KDR, PDGFRA, SMAD4, 
STK11) were noted. Moreover, three novel mutations (undescribed in 
COSMIC) with impact the melanoma biology were reported.
Conclusions: Results will be used to assess the degree of spatial in-
tratumor heterogeneity in the context of the proliferation index. This 
can revise the eligibility criteria for personalized therapies.
vitamin d metaboliSm and expreSSion of itS receptorS 
in mucouS membrane of the upper reSpiratory tract?
Katarzyna Górska, Wojciech Pinkas
Studenckie Koło Naukowe Otorynolaryngologii Ear-Nose-Throat, Warszawski 
Uniwersytet Medyczny
trustee of the paper: Mariola Zagor
introduction: Vitamin D has recently gained a lot of attention due to 
numerous studies that reveal its possible link to various diseases of the 
skin and mucous membranes, for example psoriasis vulgaris, systemic 
lupus erythematosus and atopic dermatitis. In this study, we wanted 
to evaluate its action in sinonasal mucosa epithelial cells and possible 
impact on inflammatory process that occurs in chronic rhinosinusitis.
aim of the study: We aimed to study the expression of the Vitamin D recep-
tor (VDR) and CYP27B1, 1alpha-hydroxylase which converts calcifediol into 
calcitriol, in sinonasal mucosa epithelial cells and analyze its potential chan-
ges in patients with chronic rhinosinusitis comparing to healthy controls.
materials and methods: VDR and CYP27B1 expression in 15 CRS wi-
thout nasal polyps (CRSsNP), 15 CRS with nasal polyps (CRSwNP) and 
15 control samples was assessed by immunohistochemistry. Tissue was 
gathered from the ostiomeatal complex.
results: The VDR and CYP27B1 were expressed in sinonasal mucosa epithe-
lial cells. We found that the level of VDR expression was statistically signifi-
cantly diminished in CRS patients than in controls. No statistically significant 
difference between CYP27B1 expression was found in studied groups.
Conclusions: Sinonasal mucosa epithelial cells express VDR and have 
the capacity to synthesize the active form of vitamin D3. The differences 
in VDR expression between CRS patients and healthy controls indicate 
that vitamin D3 and VDR may be engaged in the pathogenesis of CRS.
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CASE REPORTS — ORAL SESSION
low-level laSer therapy in recurrent aphthouS 
StomatitiS treatment
Maria Olejnik, Barbara Dorocka-Bobkowska 
Studium Doktoranckie w Klinice Gerostomatologii  
i Patologii Jamy Ustnej, Uniwersytet Medyczny  
im. Karola Marcinkowskiego w Poznaniu
trustee of the paper: Barbara Dorocka-Bobkowska 
introduction: Recurrent aphthous stomatitis (RAS) is a painful inflam-
matory process of the oral mucosa that may affect 10 to 30% of the 
population with unknown etiopathogenesis and numerous predisposing 
factors. Treatment of RAS may be very challenging and includes topical, 
systemic or light therapy to reduce the pain and inflammation. Low-level 
laser therapy (LLLT) is a non-invasive and atraumatic therapeutic method 
that involves local application of a high-density monochromatic narrow-
-band light source.
material and methods: A 25-year-old healthy woman was admitted 
to the Oral Pathology Clinic presenting two major aphthous ulcers on 
tonsil and palatoglossal arch. The patient referred stress and tiredness 
as a reason of lesions appearance. The treatment of previous lesions was 
coating ointment and policresulen application which was not satisfactory. 
LLLT using a diode laser with 635 nm wavelength and 100 mW power 
was administered 3 times on first, third and fourth day of the therapy. 
A control CBC test showed no abnormalities. After first session ulcers 
were less painful and the process of healing was visibly initiated. After 
three sessions lesions were painless and patient refers faster healing 
than previous ulcers.
Conclusions: Low-level laser therapy may be considered as an effecti-
ve and non-invasive method of promotion aphthous ulcers healing in 
patients with RAS.
clinical, dermoScopic and hiStological featureS of 
melanocytic tumorS of uncertain malignant potential 
— caSe SerieS
Martyna Sławińska1, 2, Wojciech Biernat1, 3, Joanna Lakomy1, 3,  
Roman Nowicki1, 2, Michał Sobjanek1, 2
1Studia Doktoranckie Wydziału Lekarskiego,  
Gdański Uniwersytet Medyczny 
2Katedra i Klinika Dermatologii, Wenerologii i Alergologii, Gdański Uniwersytet 
Medyczny 
3Katedra i Zakład Patomorfologii, Gdański Uniwersytet Medyczny
trustee of the paper: Michał Sobjanek 
introduction: Histopathological evaluation of melanocytic lesions is 
based on tissue architecture as well as on morphological features of 
particular cells. Most melanocytic lesions may be classified as benign or 
malignant. Nevertheless, in this spectrum there are some cases represen-
ting ambiguous and often heterogenic histopathological picture, which 
are classified as melanocytic tumors of uncertain malignant potential 
(MELTUMP).
material and methods: We report 10 cases (2 male, 8 female) of MELTUMP 
with clinical, dermoscopic and histopathological presentation diagnosed 
and treated surgically at Department of Dermatology, Ve nerology and 
Allergology Medical University of Gdańsk.
Conclusions: The scientific data concerning dermoscopic pre-
sentation of MELTUMP are scarce. In the presented case series 
most lesions revealed suspicious clinical and dermoscopic fea-
tures. Literature data shows that prognosis in patient with MELTUMP 
is, in most cases, favorable. Based on the latest expert recommen-
dations wide excision of the lesion is recommended, together with 
6-month follow-up and ultrasound examination of regional lymph 
nodes.
Solar lentigo, melanocytic nevuS, Seborrheic 
keratoSiS on patient’S back? SuSpiciouS leSion  
— which featureS Should be taken into conSideration 
in dermatoScopy?
Aleksandra Maciejewska, Agata Wojnarowicz
Studenckie Koło Naukowe przy Katedrze i Klinice Dermatologicznej, 
Warszawski Uniwersytet Medyczny
trustee of the paper: Anna Woźniak-Rito, Joanna Czuwara
introduction: Dermatoscopy is a non-invasive skin and mucous 
membranes examination method of melanoma. The most common 
melanoma findings in dermatoscopy include: an atypical pigmen-
ted network, asymmetry and blue-whitish veil. Lesions that do not 
meet these criteria and being melanoma, are the most difficult for 
diagnosis.
material and methods: 51-year-old woman with skin phototype 
II with one melanoma removed a year before, referred to our cli-
nic for dermatoscopy examination of her melanocytic lesions. The 
patient had a history of repetitive sunburns in her youth and many 
solar lentigo on her back. The scar after melanoma was present in 
the interscapular area. On dermatoscopy, an irregularly pigmented 
lesion few centimeters above the scar was noticed. Clinically the 
lesion did not seem suspicious. Due to melanoma history and der-
matoscopy image which showed that lesion had irregular pigment 
network, pigment concentration on the edge forming streaks, some 
homogeneous grey color in the center which were suspicious, but 
not suggestive of melanoma, was directed for a diagnostic biopsy. 
Differential diagnosis included seborrheic keratosis, solar lentigo, 
atypical melanocytic nevus and finally the combination of the above, 
collision tumor. Histopathological examination revealed melanoma 
in situ developing in the preexisting nevus. The rest of the lesion 
was totally removed showing hyperplasia of atypical melanocytes 
without residual melanoma which is an indication of melanocytic 
activation in this patient. Patient remains under regular thorough 
dermatoscopic assessment. 
Conclusions: Dermatoscopy is a very valuable diagnostic method, but 
histopathological examination decides about the final diagnosis. There-
fore, careful examination of pigmented and non-pigmented lesions in 
dermatoscopy by experienced doctors is recommended. If any atypical 
features are noticeable, it is advisable to perform a biopsy to exclude 
their malignant character.
amelanotic melanoma. what featureS Should you be 
concerned about?
Aleksandra Maciążka
Studenckie Koło Naukowe przy Katedrze i Klinice Dermatologicznej, 
Warszawski Uniwersytet Medyczny
trustee of the paper: Olga Warszawik-Hendzel
introduction: Cutaneous melanoma has been one of the most rapidly 
increasing cancers worldwide over the last decades. It is characterized 
by very early metastases, so it is important to diagnose melanoma in 
early stages. Amelanotic melanoma represents an atypical form of 
melanoma presentation. Amelanotic melanoma may present as a fre-
quently eroded exophytic nodule mimicking a pyogenic granuloma or 
haemangioma leading to delayed diagnosis. The ABCDE classic is no 
longer appropriable in this case.
material and methods: A 30-year-old pregnant female with several 
weeks history of red nodules on the left arm. Firstly, wrongly diagnosed 
as granuloma teleangiectodes. Dermoscopy revealed linear-irregular 
vessels, milky-red areas and globules. The histopathological examina-
tion confirmed the diagnosis of melanoma pT3a. The second patient is 
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a 41-year-old man with erythematous macula on the top of lower limb. 
Dermoscopy showed dotted vessels, glomerular vessels and pigment 
remnants. Pigmented Bowen disease or amelanotic melanoma was 
suspected. Excision biopsy was performed, and histopathological exa-
mination confirmed the diagnosis of the amelanotic melanoma pT1a.
Conclusions: The amelanotic melanoma is extremely rare and it is 
difficult to distinguish it from other malignant skin lesions. The urgency 
in the diagnosis should be a standard due to the severity and poten-
tial fatal consequences of amelanotic melanoma. Dermoscopy can be 
useful in early diagnosis of amelanotic melanoma but histopathological 
examination is a gold standard. 
nonSpecific preSentationS of baSal cell carcinoma. 
the uSefulneSS of dermoScopy
Michalina Derbich, Joanna Zozula, Małgorzata Marcinkiewicz
Studenckie Koło Naukowe przy Katedrze i Klinice Dermatologicznej, 
Warszawski Uniwersytet Medyczny
trustee of the paper: Olga Warszawik-Hendzel, Joanna Czuwara
introduction: Basal-cell carcinoma (BCC) is the most common skin can-
cer. Due to ambiguous clinical presentations, a correct diagnosis can be 
challenging. The aim of this study was to demonstrate four unusual BCC.
material and methods: Patient 1: 60-year-old woman wrongly diagnosed 
with tinea faciei, consulted at Department of Dermatology due to progres-
sion of the lesions. Mycological examination was negative. Dermoscopy 
showed telangiectatic arborizing vessels covered with a scale. Histopathol-
ogy proved infiltrative basal cell carcinoma. Patient 2: 43-year-old man con-
sulted due to damaged ulcerated left earlobe and pre-auricular area, in-
tensive pain and destructed left external auditory meatus. Dermoscopy 
showed features of both BCC and SCC. Histopathology proved infiltrative 
BCC with squamous changes. Patient 3: 68-year-old woman with a whitish, 
hard plaque lesions on her neck and scalp on the left side with arborizing 
atypical blood vessels was consulted. Neoplastic process was suspected 
including BCC or skin metastases. Histopathology proved lichen sclero-
sus and morphea. Patient 4: 36-year-old woman after CO2 ablative laser 
treatment of an erythematous hard, well-circumscribed lesion with many 
telan giectases and atypical blood vessels in a whitish scar-like background 
in dermoscopy. Histopathology proved infiltrative basal cell carcinoma.
Conclusions: The correct diagnosis made early on, based on non-inva-
sive imaging methods and followed by histopathology is essential for the 
diagnosis of unusual BCC, appropriate treatment choice and prognosis 
of the patient. 
differential diagnoSiS of Sarcoma kapoSi and 
metaStatic melanoma. the value of the diagnoStic biopSy
Alicja Mróz, Katarzyna Bancerz
Studenckie Koło Naukowe przy Katedrze i Klinice Dermatologicznej, 
Warszawski Uniwersytet Medyczny
trustee of the paper: Joanna Czuwara
introduction: Kaposi sarcoma is an angioproliferative disorder which is 
induced by human herpesvirus 8 (HHV-8) infection. It usually presents on 
the skin of the upper and lower extremities. Malignant melanoma is the 
most aggressive skin neoplasm which develops from melanocytes. It me-
tastasizes commonly to the other skin areas. The classic Kaposi sarcoma 
and skin metastases of melanoma may look clinically similar. That is why it 
is relevant to present a diagnostic method allowing to differentiate these 
two distinct processes. Similarly looking two cases would be presented.
material and methods: One is an 85-year-old man with multiple 
purple macules and nodules on his lower extremities. Dermoscopy 
revealed rainbow patterns, scaling surface and lacunae. The biopsy 
confirmed the diagnosis of the Kaposi sarcoma. The second patient 
is a 79-year-old woman presenting similarly looking skin lesions but 
only on the right lower leg with accompanying ulceration. During 
examination the gray-blue and black macules, nodules were detect-
ed and also a complete dystrophy of the fifth toenail was found. In 
dermoscopy irregular structureless lesions with blue-whitish veil and 
multiple colors were observed and the Hutchinson’s sign at the base of 
dystrophic nail plate. Biopsy taken from two small nodules allowed to 
make a diagnosis of in-transit metastases of melanoma coming from 
the nail matrix of the fifth toe. 
Conclusions: Kaposi sarcoma and metastatic melanoma can present 
as similarly looking papules, nodules or plaques. The biopsy is decisive 
for the diagnosis. Every suspicious skin lesion should be guided for the 
skin biopsy and pathological examination.
eStriol and policreSulen in the off-label therapy for 
high-grade vaginal intraepithelial neoplaSia (vain 3)
Alicja Szatko
Studenckie Koło Naukowe przy II Katedrze i Klinice Położnictwa i Ginekologii, 
Warszawski Uniwersytet Medyczny
trustee of the paper: Agnieszka Dobrowolska-Redo, 
Monika Kalinowska, Ewa Romejko-Wolniewicz
introduction: Vaginal intraepithelial neoplasia (VaIN) is a rare and 
asymptomatic HPV-related precancerous lesion. It occurs as a solitary 
or multifocal lesion, usually located in the upper third of the vagina. VaIN 
coexists with other lower genital tract precancerous lesions in 30−80 % 
cases. It is often diagnosed using cytology, followed by colposcopy and 
colposcopically-directed biopsy of suspicious areas. Widely approved 
therapeutic options include radical surgery, brachytherapy, laser vapo-
rization and topical 5-fluorouracil.
material and methods: A 35-year-old nulliparous patient with a history 
of premature ovarian insufficiency (POI), cervical intraepithelial neoplasia 
grade 1 and infection with HPV type 31 and 45 (both high risk) is presented. 
Her main complaint was vaginal burning sensation and pruritus. After an ab-
normal cytology result (LSIL), vulvovaginoscopy was conducted, exhibiting 
a whitish lesion arising in the posterior vaginal fornix. The histopathological 
examination revealed VaIN high grade. The patient was disqualified from 
surgical treatment and brachytherapy. The off-label short-term topical 
therapy with estriol and policresulen was applied, resulting in a regression 
of the vaginal lesion (VaIN low grade) and resolving of the symptoms.
Conclusions: An abnormal cytology result should lead to an examination 
of vaginal portion of cervix, but also to an examination of vagina and vulva. 
For patients with VaIN high grade and hypergonadotropic hypogonadism, 
new non-invasive therapeutic options should be considered. The short-
term estrogen- and policresulen-stimulated exfoliation of vaginal cells 
may lead to a noticeable improvement of the patient’s clinical condition.
patient with diffuSe, erythematouS papuleS and tenSe 
bullae — a caSe report 
Katarzyna Górska, Klaudia Suwała
Studenckie Koło Naukowe przy Katedrze i Klinice Dermatologicznej, 
Warszawski Uniwersytet Medyczny
trustee of the paper: Marta Sar-Pomian
introduction: Lichen planus pemphigoides is a rare autoimmune 
blistering disease that combines typical symptoms of lichen planus 
with subepidermal bullae. The blisters arise on lichen planus lesions 
or individually on uninvolved skin. Direct immunofluorescence of the 
perilesional skin as well as histopathological picture of the bullae are 
identical to those of bullous pemphigoid.
material and methods: A 49-year-old woman presented with diffuse 
erythematous papules and tense bullae, lasting for 7 weeks and 2 days, re-
spectively. The lesions were localized on the trunk and limbs. The mucous 
membranes were not involved. Laboratory findings revealed an increased 
concentration of total immunoglobulin E. Direct immunofluorescence 
of the perilesional skin showed strong linear deposition of C3 along the 
basement membrane zone. Histopathology revealed the presence of 
interface dermatitis with apoptotic keratinocytes in basal layer of the epi-
dermis, the presence of subepidermal bullae and superficial perivascular 
lymphohistiocytic inflammatory infiltrates. The patient was initially treated 
with oral prednisone (50 mg daily) and 0.05% clobetasol propionate oint-
ment. Because of insufficient recovery, prednisone was withdrawn and 
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methotrexate at the dose of 10 mg weekly (initially subcutaneously, then 
orally) was used. At 5-week follow-up marked improvement was observed. 
Conclusions: Coexistence of erythematous, small, shiny papules merg-
ing into rough, scaly plaques and tense blisters may indicate the diag-
nosis of lichen planus pemphigoides. The diagnosis of this condition is 
based on direct immunofluorescence and histopathology results. Most 
of the cases of disseminated disease can be successfully treated with 
systemic corticosteroids. In recalcitrant cases methotrexate can be 
effectively used.
pemphiguS SeborrhoicuS, a rare variant of pemphiguS 
foliaceuS with noSe involvement — caSe report
Justyna Ceryn
Studenckie Koło Naukowe przy Katedrze i Klinice Dermatologicznej, 
Warszawski Uniwersytet Medyczny
trustee of the paper: Joanna Czuwara
introduction: Pemphigus seborrhoicus, a mild variant of pemphigus 
foliaceus, is an autoimmune disorder characterized by the pruritic 
small flaccid intraepidermal bullae, erosions, exfoliating lesions co-
vered by yellow crust and erythema located mainly on face, upper 
chest and back. 
material and methods: A 58-year-old man was admitted to the Derma-
tology Clinic in July 2016 with one-year history of exfoliating erythema 
on his nose treated unresponsively with oral tetracycline and retinoid as 
rosacea. On admission he presented erythematous lesion with hyperker-
atosis and edema spreading his nose and several, round, well-defined, 
similar lesions on his back and one round lesion on upper chest. Der-
moscopy revealed multiple spiral extended blood vessels and yellow 
corneous plugs suggesting dyskeratosis in hair follicles. The biopsy of the 
back skin section, appearing similar to the one on the nose, detected ac-
antholytic keratinocytes under the stratum corneum especially visible in 
infundibula of the hair follicles. Direct immunofluorescence of involved 
tissue was positive, indirect IF revealed circulating pemphigus antibod-
ies reacting with the guinea pig esophagus. Pemphigus seborrhoicus 
was recognized and combined systemic therapy with prednisone and 
Imuran was started. Due to fast elevation of transaminases the treatment 
was changed into prednisone with methotrexate after one month. From 
a year now there is a progressive medical improvement. 
Conclusions: Diagnosis of pemphigus seborrhoicus includes clinical 
presentation, immunofluorescence tests and histopathology. When 
introduced treatment is ineffective then differential diagnosis should 
be taken into account. In dermatology many skin disorders may look 
similar, occur at the same location leading to diagnostic difficulties.
familial pemphiguS vulgariS with coexiStence 
hidradenitiS Suppurativa — caSe report and analySiS 
of literature 
Monika Sztupecka
Studenckie Koło Naukowe przy Katedrze i Klinice Dermatologicznej, 
Warszawski Uniwersytet Medyczny
trustee of the paper: Anna Skrok
introduction: Pemphigus vulgaris is a rare chronic autoimmune bullous 
disease that affects skin and mucous membranes. The presence of anti-
-Dsg1 and anti-Dsg3 antibodies leads to loss of connections between 
keratinocytes and formatting blisters. It is suspected that genetic pre-
disposition plays an important role in the pathogenesis of disease. Only 
a few cases of familial PV have been published.
material and methods: We report a case of a 35-year-old Greek wo-
man with erosions in oral cavity occurring since July 2017 and with 
acne inversa diagnosed 20 years ago. The woman was hospitalized in 
the Dermatologic Clinic with exacerbation of hidradenitis suppurativa, 
however solitary blisters on erythematous background on forearm 
and chest and erosions of mucosa of the mouth were found in clini-
cal examination. Interestingly, in family history patient’s mother was 
diagnosed with PV at the age of 34. DIF examination of mucosal tissue 
and IIF confirmed the diagnosis of pemphigus vulgaris in our patient. 
Clindamycin and rifampicin therapy i.v. for acne inversa was initiated as 
well as prednisone and azathioprine therapy for pemphigus vulgaris, 
with improvement of HS and PV.
Conclusions: Familial pemphigus occurs rarely. In the literature it was 
postulated that there are specific HLA haplotypes predisposing for PV. Not 
only genetic profile plays a role in pathogenesis of pemphigus, however 
triggering factors remain unknown. In our case a coincidence of two auto-
immune diseases with different pathogenesis, acne inversa (dysfunction 
of lymphocyte T) and pemphigus vulgaris (dysfunction of lymphocyte B) 
is remarkable, making an effective treatment really challenging.
acne fulminanS aS a reSult of androgen exceSS in 
a patient Suffering from pregnancy luteoma
Weronika Bronkiewicz, Aleksandra Urban, Kamil Mierzejewski
Studenckie Koło Naukowe Endokrynologii Ginekologicznej, Warszawski 
Uniwersytet Medyczny
trustee of the paper: Monika Grymowicz
introduction: Pregnancy luteoma is a benign neoplasm of the ovary 
— in most cases asymptomatic and diagnosed accidentally during 
Caesarean section or imaging procedure. Current literature describes 
less than 200 cases of this exceedingly rare disease. Very few patients 
present androgen excess syndromes such as: hirsutism, acne, lowered 
timbre of voice or clitoromegaly.
material and methods: A 29-year-old patient, was admitted to the 
hospital in 36th week of pregnancy due to worsening androgen excess 
syndromes: hirsutism, acne, decreased timbre of voice and clitoro-
megaly. Conducted laboratory tests revealed elevated serum level of 
testosterone (3869 ng/dl normal range 14−76 ng/dl), androstenedione, 
DHEA-SO4. Solid, vascularized structures, measuring 71 × 39 mm and 
63 × 32 mm were exposed in pelvic ultrasound. The entire clinical 
picture suggested pregnancy luteoma. In the 37th week of pregnancy 
the Caesarean section was performed. Histopathology revealed lesions 
characteristic of pregnancy luteoma in both ovaries. A healthy son, 
2300/59 was born. Despite normalization of hormone levels after labor, 
the lowered timbre of voice was irreversible, and the acne exacerbated 
significantly (to face, chest and back). Retinoid therapy and scar treat-
ment were performed in a dermatology clinic.
Conclusions: The rarity of such acute course of pregnancy luteoma 
may be misleading and indicate adrenal etiology or a malignant ovar-
ian tumor. Our patient is the first reported case of the acne exacerbating 
despite normalization of androgen levels — caused perhaps by the diag-
nostically undetectable androgen metabolites with unknown effects.
(meth)acrylateS aS a cauSative factor of contact 
eczema induced by hybrid manicure
Sandra Opalińska
Studenckie Koło Naukowe przy Katedrze i Klinice Dermatologicznej, 
Warszawski Uniwersytet Medyczny
trustee of the paper: Joanna Czuwara
introduction: Ultraviolet (UV)-curable (meth)acrylate monomers and 
oligomers are the main components of hybrid varnish and well-known 
contact sensitizers. So far, allergy to (meth)acrylate monomers has 
been known as professional eczema of manicurists and dentists. The 
increasing availability of UV lamps for domestic use has led to increased 
incidence of allergic contact dermatitis (ACD).
material and methods: We present five cases of ACD to acrylates 
found in hybrid varnish. In all patients nail changes were due to inflam-
mation within the nail bed and matrix. On the periungual area, intense 
exfoliating erythematous skin lesions with hyperkeratosis and deep 
fissures were detected. Such inflammation led to the onychodystrophy 
with subungual hyperkeratosis resulting in nail plate elevation and 
onycholysis. In most patients sensitization developed after months or 
even years of chronic exposure to allergen, leading to type IV allergic 
reaction. The most frequent allergens were 2-hydroxyethyl methacrylate 
(2-HEMA) and 2-hydroxypropyl methacrylate (2-HPMA). Mycological 
examination in all patients gave negative results. Also, none of them 
had any other nail disease. After hybrid manicure removal, significant 
clinical improvement, resolution of inflammation was noticed but nail 
changes persisted for several months. 
Conclusions: Increasing use of new acrylic nail products requires der-
matologists’ awareness of induced ACD, that can be confusing with 
psoriasis. Therefore, inflammatory nail abnormalities merit patch testing 
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for allergic cause. (Meth)acrylates may also induce cross-reactions with 
other acrylic compounds (used in dentures, teeth fillings, contact lenses, 
bone cement or hearing aids) and trigger severe allergic reactions when 
re-exposure occurs in a different location.
interdiSciplinary aSpectS of behçet’S diSeaSe — a caSe 
report 
Julia Nowowiejska, Aleksandra Kamińska, Małgorzata Tryniszewska, 
Julita Anna Krahel, Anna Baran, Iwona Flisiak
Studenckie Koło Naukowe przy Klinice Dermatologii i Wenerologii, 
Uniwersytet Medyczny w Białymstoku
trustee of the paper: Anna Baran
introduction: Behçet’s disease, which occurs with a frequency between 
1/15000−500000 in Europe, is a condition of unknown etiology, charac-
terized by recurrent oral aphthae and any of several systemic manifesta-
tions including genital aphthae, skin lesions, ocular disease, gastrointesti-
nal and neurological involvement, as well as vascular disease or arthritis.
material and methods: A 26-year-old patient, mentally retarded, with 
family history of four sudden deaths, was hospitalized at the Depart-
ment of Dermatology twice. He has suffered from recurring painful 
oral aphthae for 2 years. In September 2017 a small aphtha on the 
scrotum appeared, rapidly evolving into ulceration. Patient reported 
headaches and pain in the chest recurring for many years. Multiple 
additional investigations and consultations revealed heart, vascular 
and neurological abnormalities. After systemic treatment with azathi-
oprine, antibiotics, antifungals and acyclovir, as well as topical agents, 
patient’s condition improved.
Conclusions: Behcet's disease occurs in Poland very rarely, it affects 
more frequently men than women and usually appears between 20 to 
35 years of age, as the presented patient. The most common causes of 
death of such patients are aneurysm rupture or neurological complica-
tions. The prognosis for young men is poorer and strict observation is 
necessary. The disease is a great interdisciplinary problem because of 
numerous possible manifestations, that is why it requires cooperation 
of doctors of many different specialties.
porphyria cutanea tarda — caSe reportS
Marcela Nowak, Dorota Mehrholz, Adrianna Opalska,  
Wioletta Barańska-Rybak, Roman Nowicki
English Division Dermatology Student Scientific Circle, Gdański Uniwersytet 
Medyczny
trustee of the paper: Dorota Mehrholz
introduction: The porphyria cutanea tarda (PCT) belongs to the group 
of porphyrias. The gist of porphyria is a heme disorder due to acquired 
or congenital defect of hepatic enzymes. This consequently leads to 
the accumulation of porphyrins in various organs. In case of PTC, there 
is a deficiency of an enzyme- uroporphyrinogen decarboxylase. The 
most frequent factor that leads to damage of this enzyme is liver insuf-
ficiency, as a result of chronic alcoholism and exogenic estrogen intake. 
The porphyrins accumulating in the skin are decomposed under the 
influence of ultraviolet radiation, which results in skin lesions. Typical 
lesions for PCT include blisters, erosions, crusts, and milia, that arise after 
exposure to the sun. Furthermore, skin becomes thin, more susceptible 
to injuries and scarring. 
material and methods: Two cases of acquired PCT were presented. In the 
first case, alcoholism, use of hormone replacement therapy and metformin 
intake were the cause. Second patient used estrogen due to endome-
triosis. In both cases, skin changes appeared after exposure to the sun. 
Conclusions: PCT is the most common and the most treatable type of 
porphyria. PCT may be the first symptom of liver damage. This is why it 
should be diagnosed early to avoid fatal consequences.
unuSual picture of morphea — a caSe report
Jakub Żółkiewicz
Studenckie Koło Naukowe przy Katedrze i Klinice Dermatologicznej, 
Warszawski Uniwersytet Medyczny
trustee of the paper: Anna Skrok
introduction: Morphea is an idiopathic, inflammatory disorder limited 
mainly to the skin and underlying tissues, but can also affect the function 
and structure of the muscles, bones and the nervous system. Morphea is 
divided into several variants and combinations of them. Linear morphea 
and its subtype “en coup de sabre” (LSCS) are special forms of morphea. 
Linear morphea occurs on extremities and trunk, while LSCS affects 
head most frequently. Both types of morphea are present in our patient.
material and methods: We want to report the study of a 40-year-old 
woman diagnosed with morphea at the age of six. In patient’s childhood 
skin lesions progressed till the age of 15 and eventually involved dermis, 
subcutaneous tissue and muscles of the right side of the body and of 
the left side of head (LSCS). For the next 20 years there was no activity 
of skin lesions observed, nowadays new erythematous and sclerotic 
lesions appear. In 2016 our patient developed hemorrhage in left cere-
bral hemisphere, what is unusual in young age. Neuroimaging revealed 
nonspecific changes, possibly vascular lesions related with LSCS.
Conclusions: Clinical presentation of coexisting morphea lesions of one 
side of the body and contralateral side of head has been extremely rare 
in the literature. Linking CNS malformation with skin lesions localization 
and early onset of disease may suggest congenital neuronal cell mu-
tation. Etiology of LSCS still remains uncertain and needs some further 
investigation. Collecting and analyzing clinical case reports is vital to 
understand basis of this rare disease.
chilblain lupuS erythematoSuS: a challenging caSe 
report — diagnoSiS and treatment
Konrad Strzelec
Studenckie Koło Naukowe przy Katedrze i Klinice Dermatologicznej, 
Warszawski Uniwersytet Medyczny
trustee of the paper: Anna Skrok
introduction: Chilblain lupus erythematosus (ChLE) is clinically classi-
fied as a rare subtype of chronic cutaneous lupus erythematosus (CCLE) 
reported mostly in middle-aged female patients. It is characterized 
by symmetric erythematous-violaceous inflammatory plaques/nodules 
and oedematous skin mainly around the acral regions of the body 
(including the dorsal aspects of fingers and toes, as well as nose, 
cheeks, and ears), appearing after cold and wet exposure with observed 
improval tendency in the summer. The lesions commonly ulcerate, but 
usually heal without scars. Up to 20% of patients affected by ChLE de-
velop systemic lupus erythematosus (SLE) or ChLE may occur after the 
diagnosis of SLE is established. Making a diagnosis of this special form 
of LE as well as effective managing is extremely challenging. 
material and methods: We report a case of 38-year-old man presented 
with a 6-month history of an itchy ulcerative lesions on the hands asso-
ciated with carpal and digital pain and swelling, limited range of motion 
and impaired grip, who had been treated with different medications with 
no response. The patient was diagnosed with chilblain lupus (according 
to Mayo Clinic Proposal of Diagnostic Criteria). Finally, a complex therapy 
with prednisone, mycophenolate mofetil and sulodexide managed to 
control the symptoms and brought important relief as well as improved 
the quality of patient’s life. 
Conclusions: Chilblain lupus erythematosus should be considered as 
a differential diagnosis when faced with cold-induced erythematous 
lesions. The reported case suggests that putting a right diagnosis is 
crucial and aggressive complex treatment makes a control of the sys-
temic disease possible.
necrobiotic xanthogranuloma — characteriStic 
featureS of thiS rare entity
Marta Chądzyńska
Studenckie Koło Naukowe przy Katedrze i Klinice Dermatologicznej, 
Warszawski Uniwersytet Medyczny
trustee of the paper: Joanna Czuwara, Aleksandra Żerdzińska
introduction: Necrobiotic xanthogranuloma NGX is a rare histiocytic 
disease characterized by multiple nodules or plaques occurring in pe-
riorbital area. It is usually associated with malignant lymphoproliferative 
disorders, including paraproteinemias and multiple myeloma.
material and methods: We present 64-year-old woman with yellowish 
nodules on her lower eyelids and temple, infiltrating lesions on the 
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shoulders, and nodular infiltrates on her neck. She was diagnosed with 
IG-kappa type monoclonal gammopathy in 2011 (without transmission 
into multiple myeloma till now) but her skin has no changes for sev-
eral years. The patient was treated with methotrexate 10 mg per week 
(between 4−8.2017) without response. From 8.2017 till now she has 
been treated with azathioprine without improvement. Histologically 
necrobiotic xanthogranuloma is a granulomatous process of a deep 
dermis with collagen degeneration (necrobiosis) and adipose tissue 
damage with characteristic cholesterol clefts, many foamy histiocytes, 
multinucleated giant cells with Touton giant cells, lymphocytic nodular 
infiltrates, plasma cells and histiocytes.
Conclusions: Necrobiotic xanthogranuloma is a very rare disease with 
characteristic location, clinical presentation and histopathological find-
ings. The overlying paraproteinemia should be investigated in each NXG. 
The treatment of NXG is difficult with poor therapeutic response. We 
present the case based on the rule: once seen never forgotten, hoping 
it will be diagnosed easier in the future.
three caSeS of different Skin diSeaSeS with 
paraproteinemia
Magdalena Lichy1, Aleksandra Żerdzińska1, 2
1Studenckie Koło Naukowe przy Katedrze i Klinice Dermatologicznej, 
Warszawski Uniwersyt Medyczny
2Kliniczny Oddział Chorób Wewnętrznych, Dermatologii i Alergologii, Szpital 
Specjalistyczny w Zabrzu
trustee of the paper: Joanna Czuwara 
introduction: Paraprotein is a monoclonal immunoglobulin or its light 
chains, most commonly — κ, which appears in the blood or urine and 
usually derives from clonal proliferation of plasmocytes. 
A variety of dermatoses are connected with increased level of parapro-
tein, e.g. cutaneous plasmacytoma, cryoglobulinemia. Although they 
are rare, may be the first sign of underlying haematologic malignancy.
material and methods: Three cases of different skin disorders second-
ary to paraproteinemia are presented: (1) 61-year-old woman complain-
ing of diffuse nodular lesions with tenderness and pruritus on her knees 
and elbows with biopsy proven erythema elevatum et diutinum. Due to 
unexplained normocytic anemia and bone changes, she was referred 
to oncology, where m protein, increased level of plasmocytes and IgA 
κ/λ were detected. These results indicate Monoclonal Gammopathy of 
Undetermined Significance (MGUS). (2) 65-year-old woman suffering 
from hyperlipidemia, MGUS and progressive hard nodules on her neck 
and shoulders. She had numerous yellowish nodules with the foci 
of skin hardening on her lower eyelids and temples. Histopathology 
confirmed necrobiotic xanthogranuloma — a rare disease usually asso-
ciated with paraproteinemia, as in her case. (3) 73-year-old woman with 
polyclonal gammopathy and many comorbidities was admitted to 
the hospital to diagnose diffuse, progressive proximal skin hardening, 
difficulties with swallowing and arthralgia. Biopsy revealed features of 
scleredema — type of cutaneous mucinosis which may be connected 
with abnormal level of Ig in the blood. Biopsy of adipose tissue showed 
amyloid deposits.
Conclusions: Our cases concomitant with paraproteinemia imply se-
rious diagnostic and therapeutic difficulties because skin symptoms 
are only manifestation of plasmocytes dysfunction or transformation.
rare type of neurofibromatoSiS 
Maja Kotowska, Karolina Godlewska
Studenckie Koło Naukowe przy Katedrze i Klinice Dermatologicznej, 
Warszawski Uniwersyt Medyczny
trustee of the paper: Monika Łukiewicz
introduction: Neurofibromatosis is a common disorder that affects 
approximately 1 in 3000 persons. However, Segmental Neurofibroma-
tosis (NF-5) is a rare and atypical variant of neurofibromatosis, where 
the cutaneous changes are limited to one region of the body. SN is 
characterized by café-au-lait spots and neurofibromas limited to a cir-
cumscribed body region. Because of its rare occurrence, there is no 
specific guidelines regarding management.
material and methods: In October 2016, a 48-year-old female pre-
sented with lesions situated on the upper right arm. Multiple nodules 
were flesh-colored, soft and non-painful. Primarily lesions occurred 
20 years ago after pregnancy. There were no other symptoms typical 
for NF observed — cafe au lait spots, freckles in the axillary region or 
Lisch nodules. In November 2016 the tissue biopsy was performed. 
Histopathological examination indicated neurofibroma. There was no 
previous family history on NF.
Conclusions: In 1982 Riccardi classified NF into eight categories. Our 
patient presents neurofibromatosis type 5 — SN. NF is caused by po-
stzygotic mutation in the NF1 gene present on chromosome 17. The 
mutation occurs during the embryonic development and causes mo-
saicism. SN is generally not transmitted to offspring, because somatic 
mosaicism does not affect gonadal cells. Mosaicism is also associated 
with the localized character of the disorder. Neurofibromas of patients 
with NF1 commonly grow during puberty and pregnancy. Our patien-
t’s neurofibromas were strictly limited to one region of the body — right 
upper arm and occurred after pregnancy. There was no previous family 
history of NF, which is also typical for NF-5.
the role of diagnoStic biopSy in ambiguouS clinical 
and trichoScopic manifeStation of alopecia
Julia Pankiewicz, Magdalena Jedynak
Studenckie Koło Naukowe przy Katedrze i Klinice Dermatologicznej, 
Warszawski Uniwersytet Medyczny
trustee of the paper: Lidia Rudnicka, Joanna Czuwara, Anna Waśkiel
introduction: Trichoscopy is non-invasive diagnostic method of hair 
loss and scalp disorders. In most cases, trichoscopy findings are charac-
teristic for the accurate diagnosis. However, some patients need further 
differential diagnosis provided by biopsy, due to coexistence of two 
diseases, severe hair loss or unresponsiveness to treatment.
material and methods: Three women in postmenopausal age were 
admitted to the clinic presenting severe, persistent hair loss with 
the history of: Hashimoto disease, ovary carcinoma, endometriosis 
and adrenalectomy. Previous pharmacological treatment with topical 
corticoids was insufficient. Adjuvant therapy with PRP was without 
any benefit. The blood tests and trichoscopy were performed. Based 
on results and comorbidities the initial diagnosis was Female An-
drogenic Alopecia. The image of videodermoscopy showed features 
characteristic not only for FAGA as: scale, erythematous plaques and 
dilated vessels. The differential diagnosis included psoriasis, mucinosis 
follicularis, alopecia areata, eczema or early discoid lupus erythemato-
sus. In biopsies, the histopathology examination revealed Malassezia 
spp. and bacterial infundibular infection, increased percentage of 
telogen hairs, disturbances of keratinization and hair follicle minia-
turization. Telogen shift with minimal inflammation indicated diag-
nosis of telogen effluvium coexisting with AGA. In one case, diffuse 
alopecia areata was suggested. FAGA with predisposing factors: drug 
treatment, hypothyroidism, anemia, chronic illnesses, major surgery 
or stress enforce searching for additional alopecia type leading to 
hair loss exacerbation.
Conclusions: Presented cases show the important role of the biopsy in 
diagnostic process of alopecia, differentiating scarring from non-scarring 
process and identification of comorbidities in the hair follicles or dermis 
leading to increased hair loss.
amicrobial puStuloSiS of the foldS
Katarzyna Pisarz, Roman Nitskovich
Studenckie Koło Naukowe przy Katedrze i Klinice Dermatologicznej, 
Warszawski Uniwersytet Medyczny
trustee of the paper: Monika Siedlecka, Joanna Czuwara
introduction: Amicrobial pustulosis of the folds (APF) is a rare, neu-
trophilic dermatosis characterized by the presence of relapsing, sterile 
pustules involving predominantly cutaneous folds, anogenital region 
and scalp. It affects almost exclusively young women exhibiting a wide 
spectrum of autoimmune abnormalities. As the disease shares common 
clinical and histopathological features with other pustular dermatoses, 
differential diagnosis might be problematic. Due to low incidence of APF, 
data on effective therapeutic options are limited to solitary cases. The 
aim of the study is to present a patient with APF, who was successfully 
treated with topical steroids.
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material and methods: A 69-year-old man with hypertension and 
asthma presented to our department with a 3-week history of escalat-
ing pustular eruption of major skin folds with co-existing pruritus. Skin 
biopsy revealed subcorneal pustules with neutrophilic infiltrate, as well 
as psoriasiform epidermal hyperplasia with granular layer preserved. 
Direct and indirect immunofluorescence examination as well as Periodic 
Acid-Schiff (PAS) staining of the biopsy specimen gave a negative result. 
An increased concentration of anti-thyreoperoxidase antibodies with 
compensated thyroid hormones was detected. Two-week treatment 
with high-potency topical glucocorticosteroids resulted in significant 
improvement, without noticeable relapse during a 4-month follow-up.
Conclusions: In conclusion, the diagnosis of this rare entity can be 
difficult, as it can be easily misdiagnosed as more common conditions, 
such as pustular forms of psoriasis or pemphigus foliaceus. That is why 
clinicopathological correlation and search for co-existing autoimmune 
disorders play a crucial role in APF diagnosis.
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proStaglandin analogueS for the treatment of 
different typeS of hair loSS 
Agata Zielińska, Mariusz Sikora
Studenckie Koło Naukowe przy Katedrze i Klinice Dermatologicznej, 
Warszawski Uniwersyt Medyczny
trustee of the paper: Mariusz Sikora 
Bimatoprost, latanoprost and travoprost are prostaglandin F2-alfa analogues, 
commonly used to treat glaucoma. Trichomegaly and hypertrichosis of the 
eyelashes, which may occur as side effects of glaucoma therapy with topical 
prostaglandin analogues, led to clinical studies of the efficacy of these drugs 
for different forms of alopecia. Topical treatment with 0.1% latanoprost 
solution was reported to significantly increase hair density (terminal and 
vellus hairs) in a small randomized trial of men with androgenetic alopecia. 
Mechanism of action of prostaglandin F2-alfa analogues in androgenetic 
alopecia stems from stimulation and prolongation of the anagen phase in 
hair follicles. The use of prostaglandin F2-alfa analogues has also been inve-
stigated in alopecia areata. Topical application of bimatoprost 0.03% solution 
applied twice daily resulted in higher percentage of hair regrowth and earlier 
onset of initial response in comparison to mometasone furoate cream 0.1% 
applied once daily. Data on efficacy of bimatoprost on alopecia areata of the 
eyelashes are inconclusive. Topical bimatoprost may be also considered for 
the treatment of chemotherapy-induced eyelash alopecia. Prostaglandin 
F2-alfa analogues have been shown to be safe and well tolerated in adult 
and pediatric populations. Most of the reported adverse effects were mild, 
localized to the site of application and reversible after termination of the 
treatment. Most commonly reported were: conjunctiva hyperemia, pruritus, 
contact dermatitis and irritation. Additional studies with longer follow-up 
and larger sample sizes are necessary to determine whether prostaglandin 
analogues could be used for treatment of different types of hair loss.
nutrientS that prevent hair loSS
Maja Czerwińska, Joanna Hołowko, Natalia Komorniak, Joanna Palma
Pomorski Uniwersytet Medyczny w Szczecinie
trustee of the paper: Ewa Stachowska 
Hair follicle cells are among the most metabolically active cells and 
they need good supply of nutrients and energy. For this reason, nutri-
tional and energy deficiency may lead to structural abnormalities or 
hair loss. Malnutrition and inadequate supply of energy and proteins 
are common causes of hair loss. Proteins are major constituent of hair 
fibres. Crucial aminoacids include L-lysine (important for iron and zinc 
uptake) and L-cysteine (component of keratin). Furthermore, essential 
polyunsaturated fatty acids and alpha-linolenic acid deficiency can lead 
to hair loss. Insufficient iron is the most common nutritional deficiency 
that also leads to this problem. The reason is that multiple genes in 
a human hair follicle may be regulated by this nutrient. Copper is crucial 
for keratin fibre strength and an essential micronutrient for prevention 
of hair loss. Selenium plays an important role in protection against oxi-
dative damage. Studies suggest that rats suffering from its deficiency 
have sparse hair growth. Zinc deficiency may lead to telogen effluvium 
and brittle hair. Vitamin C is also important because ascorbic acid is 
crucial for collagen synthesis and cross-linage of keratin fibres. Vitamin 
D plays a role in hair follicle cycling, whereas vitamin A activates hair 
follicle stem cells. Biotin may help by increasing DNA concentration 
and protein synthesis in hair follicles. The supply of these nutrients in 
a well-balanced diet can play an important role in prevention of hair loss.
diet aS a form of prevention and treatment of atopic 
dermatitiS in infantS and Small children 
Dominika Pokrywka, Natalia Komorniak
Pomorski Uniwersytet Medyczny w Szczecinie
trustee of the paper: Beata Łoniewska
In atopic dermatitis (AD) prevention, breastfeeding plays an important 
role and hence early termination of this process is not advised. It seems 
that mothers dietary restrictions have no influence on AD development. 
As an alternative or support to breastfeeding children with high risk of 
AD development, milk replacement with hydrolyzed proteins may be 
used. For many years, among children with increased AD risk, food that 
was potentially allergenic was introduced later than it normally would. 
Current scientific evidence indicates that not only it did not decrease 
the risk but may have potentially increased it. The conclusion is that it 
is not recommended to deviate from nutrition guidelines for young 
children or introduce dietary restrictions. Before applying elimination 
diet, products that exacerbate the symptoms should be identified. 
Unjustified elimination and incorrect diet management can lead to nu-
tritional deficiencies. More and more frequently we notice a connection 
between abnormal gut microbiota and AD development and so it seems 
justified to supplement probiotics in both pregnant and breastfeeding 
women as well as newborns. Changes in gut microbiota in infancy may 
have a role in allergies development, because of its impact on immune 
system functions and development.
reStoration of the natural compoSition of the Skin 
microbiome — a novel Strategy for the treatment of 
atopic dermatitiS 
Leszek Blicharz
Studenckie Koło Naukowe przy Katedrze i Klinice Dermatologicznej, 
Warszawski Uniwersytet Medyczny
trustee of the paper: Zbigniew Samochocki
Microbiome disorders, which have been proposed as an important 
element of pathogenesis in various dermatoses, are particularly well 
studied in atopic dermatitis (AD). 16S rRNA sequencing has confirmed 
classical microbiological observations regarding the excessive coloniza-
tion of AD lesions by Staphylococcus aureus and simultaneous reduction 
of other bacterial strains of the natural microflora. It has also become 
evident that S. aureus may not only be a secondary exacerbating factor 
of the disease, but also lead to the development and perpetuation 
of skin lesions in AD. In the light of these reports, restoration of the 
proper composition of the skin microbiome has become a promising 
novel therapeutic option. Nevertheless, due to the risk of selection of 
drug-resistant strains of pathogenic bacteria and reduction of beneficial 
commensal microflora, the extent and chronic course of the disease 
and cost-effectiveness, antibiotics are not indicated in asymptomatic 
S. aureus colonization. However, promising reports considering the 
application of synthetic anti-microbial peptides (AMPs), specific bac-
teriocins derived from bacteriophages and preparations containing 
non-pathogenic commensal bacteria have, among other solutions, 
given base to the elaboration of an additional line of treatment in AD. 
This report focuses on the role of novel agents in restoring natural skin 
microbiome in AD and on the impact of this intervention on the clinical 
course of the disease.
nonalcoholic fatty liver diSeaSe, inSulin reSiStance 
and pSoriaSiS. new aSpectS of low-grade chronic 
inflammation
Anna Pasierb, Radosław Pietrzak, Paweł Rykowski
Studenckie Koło Naukowe przy Katedrze i Klinice Dermatologicznej, 
Warszawski Uniwersytet Medyczny
trustee of the paper: Joanna Czuwara
Over the past 10 years, it has become increasingly evident that no-
nalcoholic fatty liver disease (NAFLD) is a multisystem disease that 
affects multiple extra-hepatic organ systems and interacts with re-
gulation of several metabolic and immunological pathways. NAFLD 
and the metabolic syndrome are mutually and bidirectionally asso-
ciated, as these two pathological conditions share insulin resistance 
as a common pathophysiological mechanism. There is clinical and 
epidemiological evidence supporting a strong association between 
NAFLD and chronic plaque psoriasis. They share multiple inflammato-
ry and cytokine-mediated mechanisms and are part of an intriguing 
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network of genetic, clinical and pathophysiological features. It is 
conceivable that several pro-inflammatory cytokines that are locally 
over-produced by lymphocytes and keratinocytes into the skin of 
psoriatic patients may contribute to the pathogenesis of systemic 
insulin resistance. Health care providers following psoriatic patients 
should be mindful of this potentially progressive liver disease that 
is commonly observed among psoriatic patients. The presence of 
NAFLD should be also taken into consideration when choosing phar-
macological treatment, as some conventional drugs for psoriasis are 
potentially hepatotoxic.
apremilaSt — new treatment option for pSoriaSiS
Agnieszka Krasowska, Marta Hajbos, Mariusz Sikora
Studenckie Koło Naukowe przy Katedrze i Klinice Dermatologicznej, 
Warszawski Uniwersytet Medyczny
trustee of the paper: Mariusz Sikora 
Apremilast is an oral small molecule (non-biologic) inhibitor of phospho-
diesterase 4. Increase in the intracellular concentration of cyclic adenos-
ine monophosphate leads to suppression of proinflammatory cytokines 
(TNF-α, IL-12, IL-17, IL-23) production and relase of anti-inflammatory 
mediators (IL-10). The immunomodulatory effects of phosphodiesterase 
4 inhibitors have been investigated in a number of chronic inflammatory 
diseases, such as psoriasis and psoriatic arthritis.
The efficacy of apremilast in the treatment of moderate to severe plaque 
psoriasis was confirmed in preclinical in vivo models as well as in phase 
II and III clinical trials. Additionally, apremilast was also effective in the 
treatment of psoriasis in difficult to treat locations such as palms and 
soles, scalp and nails. Apremilast is generally well tolerated. The most 
common adverse effects are gastrointestinal complaints such as diar-
rhea, nausea and weight loss. They occur within the first few weeks of 
use and pass away with time. Other side effects include headaches, 
insomnia and upper respiratory tract infections. Owing to the absence 
of organ toxicity, there is no need of laboratory prescreening or ongoing 
monitoring for laboratory parameters. The advantages of apremilast 
include activity for both psoriasis and psoriatic arthritis and efficacy in 
difficult to treat forms of psoriasis, a good safety profile, oral administra-
tion. This makes apremilast an attractive therapeutic option for patients 
with psoriasis. However, cost-effectiveness and health economics should 
also be taken into account.
SurpriSing correlation: parkinSon’S diSeaSe and 
melanoma. what iS the poSSible link?
Magdalena Chrabąszcz
Studenckie Koło Naukowe przy Katedrze i Klinice Dermatologicznej, 
Warszawski Uniwersytet Medyczny
trustee of the paper: Joanna Czuwara 
Parkinson’s disease (PD) is a neurodegenerative disorder, characterized 
by depletion of dopamine in the striatum and loss of melanin-positive, 
dopaminergic neurons in the substantia nigra pars compacta. Melanoma 
is a skin cancer arising from epidermal melanocytes. The epidemiology 
of melanoma focus on well-known risk factors such as skin and hair 
color, gender, eye pigmentation and ultraviolet (UV) exposure. Several 
studies have suggested an association between PD and melanoma. The 
underlying mechanism that link Parkinson’s disease with melanoma is 
not clear but it has aroused lots of interests. More interesting is that 
the link between these diseases runs both ways. What is the underly-
ing cause of this reciprocal association? Is it due to Parkinson’s treat-
ment? Is levodopa the reason of increased incidence of melanoma in 
people with the neurodegenerative condition? Are there any genetic, 
immune system irregularities or environmental risk factor that serves 
as the common denominator between these two conditions? Should 
we consider melanoma comorbidity with Parkinson’s disease and vice 
versa? Some hypothesis include pigmentation changes in melanin 
and/or melanin synthesis enzyme like tyrosinase, autophagy deficits, 
changes of PD-related genes such as Parkin or α-synuclein. Learning 
more about the relationship between PD and melanoma may lead to 
better understanding of each disease and contribute to more effective 
treatments of both.
viSmodegib — an innovative therapeutic option for 
patientS with locally advanced or metaStatic baSal 
cell carcinomaS 
Barbara Pitak, Natalia Wąsowska
Studenckie Koło Naukowe przy Katedrze i Klinice Dermatologicznej, 
Warszawski Uniwersytet Medyczny
trustee of the paper: Olga Warszawik-Hendzel
Basal cell carcinoma (BCC) is the most common cancer in individuals 
with fair skin type. The tumor usually grows slowly and has a good 
prognosis. The gold standard of treatment of BCC remains surgical 
excision. For BCCs not suitable for surgery, topical therapies, such as 
5-fluorouracil, imiquimod, photodynamic therapy and cryotherapy 
are a therapeutic opportunity. However, all these approaches are less 
effective than surgery. In 2012 FDA approved vismodegib for patients 
with metastatic or locally advanced, recurring after surgical excision 
BCC, as well as for cases when surgery or radiation are contraindicated. 
Vismodegib blocks the sonic hedgehog pathway whose activating mu-
tation plays a key role in the pathogenesis of BCC. The main challenges 
in the vismodegib therapy are adverse effects such as muscle cramps, 
alopecia and nausea, in some cases resulting in the discontinuation of 
treatment. There were reports of developing squamous cell carcinoma 
(SCC) at distant sites or within the primary tumor bed during or after 
treatment with vismodegib. The question whether vismodegib signifi-
cantly increases the risk of SCC still remains to be answered.
the uSability of Sulodexide in dermatology
Teresa Wolniewicz, Zuzanna Osica
Studenckie Koło Naukowe przy Katedrze i Klinice Dermatologicznej, 
Warszawski  Uniwersytet Medyczny
trustee of the paper: Marta Sar-Pomian
introduction: Sulodexide, known for its antithrombotic and anti-in-
flammatory properties, belongs to the group of low-molecular weight 
heparins. The aim of this study was to evaluate the current usability of 
sulodexide in dermatological conditions.
material and methods: An electronic search of three databases (Scopus, 
Web of Science and PubMed) was performed using the following search 
terms: sulodexide AND (therapy OR treatment OR efficiency) AND (skin 
OR dermatol OR sclerosis OR morphea OR ulcer). 
results: A total of 58 articles were included into the review. A total of 
44 studies concerned venous leg ulcers and showed that oral sulodexide 
(250 or 500 LSU/day) may serve as an effective adjuvant therapy. Seven 
articles regarded diabetic foot leg ulcers. Four out of seven records fo-
cused on the usability of sulodexide in oral lichen planus. In one study, 
the mean time needed for complete clinical resolution equaled 23 and 
36 days in sulodexide and topical cyclosporine group, respectively. Two 
publications revealed that oral sulodexide used in recurrent aphthous 
stomatitis has less severe adverse effects than oral prednisone. One 
study showed efficacy of sulodexide in localized scleroderma, adminis-
tered both orally (500 LSU/day) and intravenously (600−1.200 LSU/day). 
Another study showed that both parenteral (1.200 LSU/day for 3−4 days 
every 4−6 weeks) and oral (500 LSU/day) sulodexide reduces the risk 
of complications of impaired microcirculation in systemic sclerosis.
Conclusions: Sulodexide is an effective adjuvant therapy for venous 
leg ulcers. Further investigations are needed to evaluate its efficacy in 
other dermatological conditions.
differential diagnoSiS of progreSSive cutaneouS 
ScleroSiS and itS cauSeS
Anna Misiołek, Leszek Blicharz
Studenckie Koło Naukowe przy Katedrze i Klinice Dermatologicznej, 
Warszawski Uniwersytet Medyczny
trustee of the paper: Joanna Czuwara
Progressive cutaneous sclerosis is a state that may involve dermis, sub-
cutaneous tissue and underlying soft tissues. It can be either deep or 
broad and be secondary to various systemic disorders, from benign to 
life-threatening ones. Due to its potentially lethal causes, it is essential 
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to thoroughly diagnose the patients with signs of rapidly progressing 
skin hardering. Apart from detailed interview and thorough physical 
examination, histopatological examination of the skin lesion, immu-
nohistochemical staining, blood analysis and other laboratory tests 
can be very helpful in differential diagnosis. Hematological diseases, 
such as paraproteinemias or their more severe form — plasma cell 
dyscrasias — can be distinguished as possible culprits of progressi-
ve cutaneous sclerosis. Examples of skin conditions associated with 
monoclonal gammapathies include amyloidosis, POEMS syndrome, 
scleromyxedema, scleredema and eosinophilic fasciitis. Thickening of 
the skin can also occur in mycosis fungoides — the most common 
cutaneous T-cell lymphoma. Correct diagnosis is crucial as some forms 
of progressive cutaneous sclerosis can withdraw after introduction of 
proper treatment of the underlying disease. This presentation provides 
clinical and morphological clues to differentiate various presentations of 
progressive cutaneous sclerosis and diseases or systemic disturbances 
which can be hidden as the cause of skin hardening.
targeting fibroSiS in SyStemic ScleroSiS — what iS new 
in baSic and clinical ScienceS? 
Aleksandra Iwanowska, Mariusz Sikora
Studenckie Koło Naukowe przy Katedrze i Klinice Dermatologicznej, 
Warszawski Uniwersytet Medyczny
trustee of the paper: Mariusz Sikora 
Systemic sclerosis is a chronic, systemic autoimmune disease, cha-
racterized by progressive fibrosis of the skin and internal organs. The 
pathogenesis of systemic sclerosis is complex and not completely 
understood. Most theories tend to focus on the interplay between 
immunological events and vascular changes. Recent advances in the 
understanding of molecular and cellular pathways involved in fibrosis 
allow to develop new targeted therapeutics. The central mediator of 
fibrosis in systemic sclerosis is transforming growth factor-β (TGF-β). 
This pleiotropic cytokine stimulates fibroblasts to proliferate and pro-
duce extracellular matrix components. Fresolimumab, a monoclonal 
antibody against TGF-β, was shown to decrease skin fibrosis in patients 
with early diffuse cutaneous systemic sclerosis. Another drug target-
ing the TGF-β pathway abituzumab (antibody against αv integrin) is 
currently being evaluated in phase 2 clinical trial. Promising results 
from a small clinical and observational studies highlight the potential 
efficacy of B-cell depletion therapy with rituximab in systemic sclerosis 
associated interstitial lung disease. Interleukin-6 is secreted by activat-
ed immune cells and plays important role in fibroblast accumulation. 
Blockade of interleukin-6 receptor with tocilizumab reduces skin and 
lung fibrosis. Given the role of vascular damage in systemic sclerosis, 
the use of riocyguat, stimulator of the soluble guanylate cyclase, has 
additionally antifibrotic effect. A number of other new therapeutics is 
currently under evaluation for systemic sclerosis. The diversity of the 
available strategies raises hope for starting a new era in the treatment 
of fibrotic diseases.
lichen ScleroSuS — between dermatology and 
gynaecology 
Alicja Witkowska, Anna Kuźminko, Justyna Skibińska
Studenckie Koło Naukowe przy Katedrze i Klinice Dermatologicznej, 
Warszawski Uniwersytet Medyczny
trustee of the paper: Justyna Skibińska, Małgorzata Olszewska
Lichen sclerosus (LS) is a chronic, inflammatory, mucocutaneous disorder 
that most commonly afects genital and perianal areas. The etiology of 
lichen sclerosus is unclear, and may include genetic, hormonal, irritant, 
traumatic and infectious factors. LS may occur at any age but is usually 
diagnosed in prepubetral and postmenopausal women. Typical skin 
lesions are white atrophic plaques that can result in genital scarring 
and adhesions with a risk of developement of squamous cell carcino-
ma. The diagnosis should be confirmed with a skin biopsy and early 
treatment should be initiated. High-potent topical corticosteroids are 
used in first-line treatment of lichen sclerosus. Second-line therapy 
includes calcineurin inhibitors. Topical and systemic retinoids, steroid 
injections, cyclosporin and methotrexate should be applied when the 
previously mentioned methods are ineffective. Surgery should be re-
stricted to patients with functional impairments. Consistent long-term 
treatment can decrease the risk of development of squamous cell car-
cinoma connected to genital area. The anogenital location of lesions 
and typical profile of patients indicates the need for close cooperation 
between a dermatologist and a gynecologist in a long-term treatment 
and follow-up of LS.
pathogenicity of environmental chlamydiae for 
humanS and animalS 
Joanna Palma, Małgorzata Pawlikowska-Warych, Wiesław Deptuła, 
Natalia Komorniak, Joanna Hołowko, Maja Czerwińska-Rogowska,  
Ewa Stachowska
Zakład Biochemii i Żywienia Człowieka, Pomorski Uniwersytet Medyczny 
w Szczecinie
Katedra Mikrobiologii, Wydział Biologii, Uniwersytet Szczeciński
trustee of the paper: Ewa Stachowska
More and more attention has been paid to environmental chlamydiae 
in recent years. They were classified as pathogenic bacteria for both 
humans and animals. Thanks to molecular biology techniques, the fol-
lowing nine families of environmental chlamydiae were assigned to the 
order of Chlamydiales: Candidatus Clavichlamydiaceae, Criblamydiaceae, 
Parachlamydiaceae, Candidatus Piscichlamydiaceae, Rhabdochlamydia-
ceae, Simkaniaceae, Waddliaceae, Candidatus Actinochlamydiacae and 
Candidatus Parilichlamydiaceae. These bacteria are considered the infec-
tious factors of zoonoses due to the fact that they can be found among 
pets and livestock such as cats, guinea pigs, sheep, cattle and even fish. 
Many of these animals also suffer from diseases caused by these bacte-
ria. While characterizing environmental chlamydiae, special attention 
has been paid to illnesses of the respiratory tract caused by Simkania 
negevensis, and to the miscarriages in people and ruminants caused 
by Waddlia chondrophila. Furthermore, the species of the Rhabdochla-
mydiaceae family as well as the bacteria from the Parachlamydiaceae 
family are responsible for eye illnesses in humans and animals. Lastly, 
newly discovered fish chlamydiae which are potential pathogenic factors 
in humans and terrestial animals are also presented.
drug induced lupuS erythematoSuS 
Weronika Pucek, Maria Kania
Studenckie Koło Naukowe przy Katedrze i Klinice Dermatologicznej, 
Warszawskiego Uniwersytetu Medycznego
trustee of the paper: Marlena Majkut-Sobechowicz
Drug-induced lupus erythematosus (DILE) is a term referring to an auto-
immune disorder caused by specific medication use and characterized 
by clinical and immunopathological features comparable to those 
found in idiopathic LE. In contrast, the onset of symptoms of DILE 
is slower, milder and strongly linked to continuous drug exposure. 
It passes away after termination of the treatment and can re-occur 
when medication is used again. The time needed for symptoms to 
occur may vary from several days to years of chronic drug administra-
tion. Three distinct types of drug-induced lupus have been reported: 
systemic DILE, subacute cutaneous (DISCLE) and chronic cutaneous 
drug-induced lupus. Unlike LE, DILE does not show female predilection 
and the mean age of its onset is generally higher. The first DILE was 
described in 1945 after sulfasalazine use and in 1985 hydrochlorothia-
zide was found to be causing DISCLE. The list of numerous xenobiotics 
linked with the condition includes antihypertensives (hydralazine, 
methyldopa), antiarrhythmics (procainamide), antibiotics (isoniazid, 
minocycline), diuretics, antipsychotics and others. In recent years, 
biological therapies with TNF-alpha inhibitors as DILE-inducing agents 
have been reported. Due to their broader use in medicine, the number 
of DILE caused by anti-TNF-alpha is still growing. No formal diagnostic 
criteria have been formulated but rather sets of guidelines are used to 
standardize and facilitate the diagnosis and to distinguish between the 
drug-induced and idiopathic form. Discontinuation of the implicated 
drug is the principal action in the management of DILE but in more 
severe cases the use of immunosuppressive agents and glucocorti-
coids should be considered.
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ocular manifeStationS in autoimmune bullouS 
diSeaSeS
Anna Zacharzewska, Aleksandra Hus
Studenckie Koło Naukowe przy Katedrze i Klinice Dermatologicznej, 
Warszawski Uniwersytet Medyczny
trustee of the paper: Małgorzata Olszewska
Autoimmune bullous diseases are a group of disorders which affect skin 
and mucous membranes. Ocular involvement is observed in about 70% 
of patients with mucous membrane pemphigoid. Patients with the di-
sease present chronic cicatrizing conjunctivitis, symblepharon, cicatricial 
entropion, and trichiasis. The disease can lead to corneal ulcerations, 
symptoms of dry eye and consequently to progressive vision loss and 
blindness. Paraneoplastic pemphigus or paraneoplastic autoimmune 
multiorgan syndrome is another autoimmune disorder with frequently 
observed ocular involvement. There are reports in the literature about 
cicatrizing conjunctivitis with symblepharon formation and corneal 
melting. Ocular involvement can be rarely observed in pemphigus vul-
garis. One of the most common symptoms is non-scarring conjunctivitis 
and erosions of conjunctiva. Patients with ocular lesions in the course 
of pemphigus vulgaris complain of pain and photophobia. The treat-
ment of patients with ocular symptoms in the course of autoimmune 
bullous disorders is challenging. Therapy consists of glucocorticosterids 
and various adjuvant immunosuppressive agents. In conclusion, early 
detection and adequate treatment of ocular symptoms are of signifi-
cant importance for preserving vision in patients with autoimmune 
bullous diseases.
primary cutaneouS b-cell lymphomaS
Anna Wrona
Studenckie Koło Naukowe przy Katedrze i Klinice Hematoonkologii 
i Transplantacji Szpiku, Uniwersytet Medyczny w Lublinie
trustee of the paper: Monika Podhorecka
Primary cutanoeus lymphomas are rare heterogenous malignant neo-
plasms which at the moment of diagnosis are located only on the skin. 
Most of primary cutanoeus lymphomas are associated with T-cell lym-
phomas, however 25% of them are B-cell lymphomas. Primary cutano-
eus B-cell lymphomas (CBCL) are thought to be less important than the 
T-cell group because they are less common. The annual incidence of 
B-cell lymohomas is about 0.3 per 100 000 population. The pathogenesis 
of B-cell lymphomas is incompletely known. Pathogenesis is usually 
associated with genetic, immunological and enviromental factors. The 
clinical presentation can be various in different patients and depends 
on the type of lymphoma. In the CBCL group we can distinguish pri-
mary cutanoeus follicle centre lymphoma, primary cutanoeus marginal 
zone lymphoma and primary cutanoeus diffuse large B-cell lymphoma, 
leg type. The base of diagnosis are clinical features, histopathological 
examination of the skin, sometimes the lymph node and also immuno-
phenotype of the lymhocytes. The aim was the description of clinical 
features, diagnosis, differentiation and treatment of primary cutanoeus 
B-cell lymphomas.
dermatological diet
Michał Czaplejewski, Zuzanna Kudas, Kinga Szczepanik,  
Justyna Grabanowska-Jaroszewicz
Studenckie Koło Naukowe Historii Medycyny, Warszawski Uniwersytet 
Medyczny
trustee of the paper: Ewa Skrzypek
Dermatology is a field of medicine specializing in examining and de-
scribing the structure as well as functions of the skin and its appenda-
ges. Dermatologists diagnose numerous skin diseases based on skin 
structure changes. Many systemic diseases can be also detected on skin 
symptoms. Specific symptoms are crucial for the disease recognition 
and diagnosis and some of them possess complicated names, therefore 
it may be hard to pronounce and remember them. But some of these 
symptoms names resemble everyday objects.
According to the dictionary of the Royal Spanish Academy an eponym 
is the use of the name of a person or place to designate a town, peri-
od, disease, unit of measure, or whatever. In medicine, eponyms are 
descriptive names used as referrral to a disease, syndrome, clinical 
sign, surgical technique, or device. The use of an eponym very often 
pays homage to the physician who first described the condition. 
Eponyms may also refer to the name of the patient whose case con-
tained the first description of a disease. We will give many examples 
of dermatological eponyms originating from foods as well as fruits, 
which we can commonly find in our fridge, for instance, blueber-
ry muffin. This dessert reminds us of a newborn with purple skin 
changes, who has neonatal purpura of congenital rubella syndrome 
also known as CRS.
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pSoriaSiS — ocular manifeStationS
Kornelia Pietrauszka, Olga Zjadewicz, Joanna Ziółkowska, 
 Mateusz Kowal
Koło Naukowe przy Katedrze i Klinice Dermatologii,  
Śląski Uniwersytet Medyczny
trustee of the paper: Beata Bergler-Czop
introduction: Around 10% of the patients with psoriasis complain from 
eye problems. They are believed to be caused by immune disturbances 
and applied treatment.
aim of the study: An assessment of visual disturbances in patients 
with psoriasis.
materials and methods: 279 patients with psoriasis were asked to par-
ticipate in questionnaire survey. Several factors were analyzed: ophthal-
mic symptoms, connection between them and psoriasis and character 
of psoriasis as the underlying disease. Study group was compared to 
the control group consisting of 135 respondents.
results: 49% of the psoriatic patients complained from ocular symp-
toms. Women were more likely to develop eye changes than man regard-
less of clinical variant of psoriasis. There was no statistical significance in 
the duration of the disease between patients with and without ocular 
manifestations. Patients with psoriatic arthritis were more predisposed 
to ophthalmic disturbances. Three symptoms: sudden change in visual 
acuity, severe eye pain, blurred vision were statistically significant and 
were more often observed. 57% of the patients using external treatment 
complained from eye symptoms.
Conclusions: The most predisposing to ocular disorders type of psori-
asis is psoriatic arthritis. Women are more likely to develop ophthalmic 
dysfunction what can be associated with autoimmune reactions, more 
often observed in females. Four of analyzed ocular symptoms are a part 
of clinical picture of anterior uveitis. Patients external treatment are 
more likely to develop ocular changes. Regarding the general treatment 
retinoids can cause burning sensation, itchy eyes and dry eye syndrome 
in patients with psoriasis.
pSoriaSiS — the influence of Smoking on the 
development and courSe of the diSeaSe
Katarzyna Gontarz 
Gdański Uniwersytet Medyczny
trustee of the paper: Agnieszka Owczarczyk-Saczonek
introduction: Cigarette smoking influence the development of 
multiple disorders and chronic diseases. According to World He-
alth Organisation (WHO) it kills more than 5 mln people each year 
and is responsible for the death of one out of ten adults. The risk 
of developing psoriasis is higher among actual and past smokers 
comparing to a non-smoking population. Nicotinism is also known 
to exacerbate the course of the disease. Cigarette smoking leads to 
an increased production and release of free radicals and is the cause 
of “oxidative stress”. Free radicals stimulate some of prostaglandin-
-independent cell signaling pathways that are known to be involved 
in the pathogenesis of psoriasis. However, it should be emphasised, 
that suffering from psoriasis, is a source of stress itself, leading to 
decreased self-esteem and causing the patients are more likely to 
reach for alcohol and cigarettes.
aim of the study: The aim of the study was to analyze a group of nicotine 
dependent psoriatic patients in terms of correlation between the strength 
of addiction and the prevalence and severity of the disease course. 
materials and methods: The study reveals the analysis of cigarette 
addiction among a group of psoriatic patients with the use of Fagerström 
Test for nicotine dependence.
results and conclusions: The results and conclusions are still being 
evaluated in comparison to a group of nonsmoking patients, regarding 
their age and sex.
the effect of StreSS on the formation of Skin SelionS
Izabela Paluch, Adrian Dwojny, Katarzyna Zięba 
Studenckie Koło Naukowe Chorób Wewnętrznych i Onkologii Klinicznej,  
Śląski Uniwersytet Medyczny
introduction: Stress is an indispensable element of our lives. It has many 
implications and essentially contributes to the disruption of homeostasis 
and the emergence of many diseases. The skin, however, as the largest 
organ of the common coat, has many functions and, as in the mirror, 
all the changes taking place in the body reflect it. 
aim of the study: Evaluation of the impact of stress on the time and 
severity of the skin lesion unit.
materials and methods: The study included 100 students aged 19 to 
28 years. A questionnaire was used to conduct the study, consisting of 
22 questions on, among others, skin changes and diseases, lifestyle, 
stress factors and two questions regarding student self-assessment. 
A file is also attached. The whole was developed in Excel 2013 and 
analyzed.
results: As a result of the data analysis, it can be stated that 91% of 
people observe reactions to stress and 100% of people experience 
stress during the year. Most respondents indicate the development of 
skin lesions, 64% think that there is a significant relationship between 
the stress and the occurrence of ailments.
Conclusions: Stress has a very large impact on the induction of skin lesions 
and on their development, also affects exacerbation of already existing 
ailments. Stress acts on the skin through a strong modulating effect of 
the neuro-endocrine-immune system. Therefore, the occurrence of stress-
-dependent dermatoses should be treated interdisciplinary using multidi-
mensional dermatological, psychological and psychiatric procedures.
role of Swi/Snf chromatin remodeling complex  
in mucoSal inflammatory diSeaSeS
Karolina Bieńkowska 
Studenckie Koło Naukowe Otorynolaryngologii przy Klinice 
Otorynolaryngologii Wydziału Lekarsko-Dentystycznego,  
Warszawski Uniwersytet Medyczny
trustee of the paper: Mariola Zagor
introduction: SWI/SNF is a chromatin remodeling complex which plays 
role in the suppression of human oncogenesis and probably inflamma-
tory response. It can be important in pathophysiology of mucosal in-
flammatory diseases. We hypothesize that one of the reasons of chronic 
rhinosinusitis (CRS) relates to the SWI/SNF complex. 
CRS is one of the most common chronic human diseases with the esti-
mated prevalence of 11% among European populations. The causes of 
CRS remain uncertain although presumable etiology and pathophysi-
ology of CRS have long been known.
aim of the study: The aim of study is the assessment of the protein 
expression level of the SWI/SNF complex subunits (BAF155, BRM and 
BRG1) in the nasal cavity mucosa from patients with CRS.
materials and methods: Samples of nasal mucosa were taken from pa-
tients during functional endoscopic sinus surgery: 30 patients suffering 
from chronic sinusitis with and 30 without polyps and as control group 
— 30 patient without CRS whom underwent septoplasty.
Activities of subunits BAF155, BRG1 and BRM were measured in mole-
cular examination.
results: Results of the observation have revealed smaller amount of the 
SWI\SNF complex in the CRS groups in comparison to the control group. 
A significant lower level of the complex was noticed in the CRS with po-
lyps group, compared to the control group and the group without polyps.
Conclusions: The role of SWI/SNF in mucosal disorders should be ana-
lyzed. The thorough knowledge about the CRS pathophysiology is 
crucial for clinicians to improve the patient treatment and helps to avoid 
potential complications.
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Uniwersytet Medyczny w Białymstoku
trustee of the paper: Anna Baran
introduction: Melanoma represents only 2% of all skin neoplasms 
nevertheless it is the most malignant skin neoplasm. It is a great in-
terdisciplinary health problem because the morbidity and fatality still 
increase, approximately it doubles every 10 years.
aim of the study: Assess the knowledge of medical and non-medical 
faculties students regarding melanoma, its risk factors and responders’ 
sun protection-associated habits.
materials and methods: In 2016 an original anonymous survey was 
carried. 277 subjects responded. They filled 17 questions: general re-
garding responders’ information and specific regarding melanoma. 
Statistical analysis was performed using Chi-Square test, statistically 
significant difference was at p < 0.05.
results: In the group 76% were females and 24% males. The most common 
skin phototype was type II (34%). More than one sun burn in the past was 
reported by 69%. Possessing less than 50 moles was reported by 67% 
of responders and more than 50 by 23%. One responder had history of 
melanoma. It was also diagnosed among grandparents and distant rela-
tives in 3%, among parents in 2%. Most of responders (92%) considered 
melanoma as a malignant neoplasm, while 4% as a benign lesion and 4% 
did not know what it was. There was no statistically significant difference 
between groups regarding sun-exposure behaviors, sun protection and 
knowledge of risk factors of melanoma. Medical students statistically signif-
icant better-identified features of moles that may be related to malignancy.
Conclusions: Almost every responder identified melanoma correctly as 
a malignant neoplasm, nevertheless awareness of the risk factors for melano-
ma is insufficient what contributes to the increasing incidence of the disease.
cutaneouS Side effectS in oncological treatment and 
decreaSing of patientS’ Quality of life  
— a QueStionnaire Study
Dominika Ragin, Izabela Ludwiczak, Katarzyna Nowacka,  
Magdalena Basałygo, Barbara Zegarska
Collegium Medicum im. Ludwika Rydygiera w Bydgoszczy, Uniwersytet 
Mikołaja Kopernika w Toruniu
trustee of the paper: Barbara Zegarska
introduction: Cancer is second — after cardiovascular diseases — most 
common cause of death in Poland. Due to increased frequency of che-
motherapeutic use and combined oncological treatment, there are more 
and more reports on toxic effect of oncological therapy on the skin, its 
appendages and mucous membranes.
aim of the study: The aim of the study was to gather information about 
different types of skin toxicity during anti-cancer treatment. Secondary 
purpose was to get to know, how much it affects patients quality of life.
materials and methods: A study of 50 patients undergoing oncological 
treatment in Oncological Centre in Bydgoszcz was performed. Using 
the authorial questionnaire, the types of skin problems, their duration 
and frequency were analyzed. Moreover, the influence of skin changes 
on patient comfort was studied using Dermatology Life Quality Index. 
Analysis of collected data was done by using Statistica 13 programme.
results: Research has shown that most of oncologically treated patients 
experience side effects concerning the skin or its appendages during 
the therapy. Frequency of skin changes occurrence varies depending 
on skin problem type, type of the medication and also individually. Data 
has not shown any correlation between sociodemographic profile and 
the cutaneous manifestations.
Conclusions: Studies on cutaneous side effects caused by anti-cancer 
treatment will allow developing standards and protocols of proper skin 
care. This could lead to the increase of quality of life in oncological patients. 
It should also be noticed that various medications are often simultaneously 
used and it is difficult to assign undesirable symptoms to a specific drug.
rehabilitation in SyStemic ScleroSiS — an eaSy way to 
improve patient compliance
Beata Polkowska-Pruszyńska, Justyna Buś, Angelika Bielecka, 
Aleksandra Szczepanek
Studenckie Koło Naukowe przy Katedrze i Klinice Dermatologii, Wenerologii 
i Dermatologii Dziecięcej, Uniwersytet Medyczny w Lublinie
trustee of the paper: Dorota Krasowska, Agnieszka Gerkowicz
introduction: Systemic sclerosis is a chronic connective tissue disease 
of a complex etiology. Due to the skin fibrosis within the fingers it leads 
to the joint mobility limitation and contractures which result in a signi-
ficant loss of hand mobility. The appropriate rehabilitation programs 
can prevent or delay the formation of contractures.
aim of the study: The purpose of the study was to compare the efficacy 
of home exercises alone and home exercises combined with paraffin 
bath treatment in hand rehabilitation of patients with systemic sclerosis.
materials and methods: The pilot program involved two groups of 
patients. The first group (11 patients) performed home exercises for 
a month. The second group (12 patients) apart from performing home 
exercises underwent paraffin bath treatment for one week. Hand mo-
bility was assessed using HAMIS test. The second group of patients was 
also assessed subjectively with VAS scale.
results: In both groups majority of patients showed improvement in 
the HAMIS test (respectively 7 and 8 patients). 4 patients from both 
groups received the same results. The mean improvement in HAMIS 
test in group 1 and 2 was 0.91 and 2 points respectively. Improvement 
was observed also in VAS scale. All patients from the second group were 
strongly willing to continue the therapy.
Conclusions: The preliminary observations confirm the effectiveness of 
both rehabilitation programs in improving the motion range of patients 
with systemic sclerosis. Nevertheless, the combined therapy seems to 
give better results and enforces the patient compliance and concordance.
granuloma annulare — Still enigmatic diSeaSe. 
a retroSpective analySiS of patientS 
Julia Nowowiejska, Monika Emilia Król, Magdalena Pałdyna,  
Anna Baran, Iwona Flisiak 
Studenckie Koło Naukowe przy Klinice Dermatologii i Wenerologii, 
Uniwersytet Medyczny w Białymstoku
trustee of the paper: Anna Baran
introduction: Granuloma annulare (GA) is an inflammatory skin disease 
of uncertain etiology and epidemiology, characterized most commonly by 
firm papules and erythematous annular plaques with predilection for limbs.
aim of the study: Retrospective analysis of medical records of patients 
with GA.
materials and methods: Ten-year retrospective analysis of patients 
hospitalized with GA at the Department of Dermatology. Gender, age 
of patients, comorbidities, clinical course of the disease and treatment 
were considered. Results were analyzed using Chi-squared test.
results: In this period 52 patients were hospitalized with GA — 37 fe-
males and 15 males. Age of patients ranged from 5 to 79 years, average 
50.58. The history of skin lesions ranged from one week to eight years, 
in 80% of patients they persisted for at least one year. The most com-
mon skin manifestation was erythema (62%) and papules (60%) with 
annular arrangement in 71% cases. Lesions were localized most often 
over the limbs: lower (79%) and upper (77%); in 81% patients they 
were observed in more than one area, in 23% a generalized variant was 
diagnosed. The most common comorbidity was arterial hypertension 
(38%), hypercholesterolemia (27%), carbohydrates metabolism disor-
ders (23%) and thyroid diseases (21%). Three patients reported present 
or past neoplasms occurrence; 63% patients had excess body weight.
Conclusions: The analysis confirmed GA is a disease of a chronic 
course affecting more often women than men as well as overweight 
patients. Hypercholesterolemia was observed more frequently in pa-
tients in GA. The relationship between GA and malignancies remains 
uncertain, however in patients with atypical, disseminated manifesta-
tions, neoplasm investigation should be considered.
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CASE REPORTS — ORAL E-POSTER SESSION
ingenol mebutate treatment in actinic keratoSiS  
— clinical effectiveneSS and potential Side effectS
Anna Maćkowska 
Studenckie Koło Naukowe Dermatologii Eksperymentalnej, Klinicznej 
i Zabiegowej przy Klinice Dermatologii, Dermatologii Dziecięcej 
i Onkologicznej, Uniwersytet Medyczny w Łodzi
trustee of the paper: Aleksandra Lesiak
introduction: Actinic keratosis is a common skin disease that occurs 
in response to prolonged exposure to ultraviolet radiation. This pro-
blem affects up to 60% of the population over 40 years of age. Actinic 
keratosis is considered to be a precancerous lesion leading to SCC. The 
new therapeutic option for the treatment of actinic keratosis is ingenol 
mebutate gel (0.015%, 0.05%).
material and methods: 10 patients with actinic keratosis lesions on 
face or scalp self-applied a 0.015% gel for 3 consecutive days on the 
25cm2 marked area. They were assessed at baseline and day 4, 7, 14, 57. All 
patients on day 57 presented a complete absence of AK lesions in the 
area of ingenol mebutate application. No adverse events were observed.
Conclusions: Our study and all reviewed studies show that ingenol 
mebutate is highly efficacious and induces a generally temporary and 
mild to moderate local skin response. Even in cases where severe skin 
reactions appear, the final cosmetic effect is good and satisfying for 
patients. These findings suggest that ingenol mebutate could be a first 
line field treatment for actinic keratosis.
melkerSSon-roSenthal Syndrome in a patient with 
ankyloSing SpondylitiS treated with etanercept
Aleksandra Wnuk
Studenckie Koło Naukowe Dermatologii i Wenerologii, Uniwersytet Medyczny 
im. Karola Marcinkowskiego w Poznaniu
trustee of the paper: Dorota Jenerowicz 
introduction: Melkersson-Rosenthal syndrome is a rare condition af-
fecting the nervous system and skin. Fully symptomatic form is cha-
racterized by recurrent orofacial swelling, recurrent facial paralysis and 
a fissured tongue. Nevertheless, the presence of the complete triad 
in a patient is relatively rare — in app. 25% of all cases. A significant 
phenomenon is cheilitis granulomatosa, which makes it possible to 
investigate the Melkersson-Rosenthal syndrome within the group of 
granulomatous diseases, such as sarcoidosis or Crohn’s disease.
material and methods: The 55-year-old woman with a persistent ede-
ma of the upper lip was admitted to our Department, as she showed no 
response to antihistamine therapy, glucocorticoid treatment and topical 
tacrolimus. The presence of a fissured tongue was also found in the 
physical examination. The Melkersson-Rosenthal syndrome was diag-
nosed on the basis of the clinical picture as well as the histopathological 
examination. The patient has been suffering from ankylosing spondylitis 
for 23 years and she was treated with etanercept for a few months 
before the occurrence of edema. Because of the possible side effects 
of etanercept treatment, the medicine was later replaced by infliximab.
Conclusions: It seems that in anti-TNF-treated patients, sarcoid gran-
ulomatous reactions of various kinds are observed more frequently for 
a soluble receptor in the dimeric form than for the anti-TNFα monoclonal 
antibody. This may be caused by etanercept’s different biological prop-
erties as well as medicines such as infliximab or adalimumab.
Superficial pyoderma gangrenoSum after orthopedic 
Surgery: a caSe report
Klaudia Walczak, Anna Żurawska
Studenckie Koło Naukowe przy Katedrze i Klinice Dermatologicznej, 
Warszawski Uniwersytet Medyczny
trustee of the paper: Alicja Kryst, Marta Sar-Pomian
introduction: Pyoderma gangrenosum (PG) is a rare inflammatory skin 
disorder of unknown etiology characterized by rapidly evolving necrotic 
ulcers with undermined edges. In many cases, lesions often occur at 
a site of surgery in an immediate post-operative period, as a result of 
a phenomenon defined as pathergy.
material and methods: We present an 81-year-old patient with 
a non-healing wound in the left wrist after an anastomosis of the distal 
end fracture with a plate and screws. Initial therapy according to the 
guidelines for the treatment of ulcers proved to be challenging and 
insufficient. Immunohistochemistry findings showed increased kappa 
serum light chain titer, normocytic anemia and hypoalbuminemia. 
Eventually histological examination defined the nature of neutrophilic 
dermatosis. The final diagnosis of pyoderma gangrenosum was con-
firmed by collecting together clinical features and biopsy findings and 
successful systemic corticosteroid therapy was performed. 
Conclusions: We showed that pyoderma gangrenosum represents a di-
agnostic and therapeutic challenge, because of the difficult differential 
diagnosis of painful ulceration mimicking infection of the operative site. 
There is no gold standard of treatment for PG. Therefore the disease 
should always be suspected when painful ulceration is aggressively 
progressing on surgical sites.
pemphigoid geStationiS — aS a riSk factor for 
additionally pregnancy complicationS 
Magdalena Chrabąszcz
Studenckie Koło Naukowe przy I Katedrze i Klinice Położnictwa i Ginekologii, 
Warszawski Uniwersytet Medyczny
trustee of the paper: Damian Warzecha, Katarzyna Kosińska-Kaczyńska
introduction: Pemphigoid gestationis (PG) is a rare autoimmune sub-
epidermal blistering disease occurring in the second or third trimester 
of pregnancy. It typically manifests with inflammatory skin lesions and 
severe pruritus, starting around the umbilicus and spreading around 
the whole body. Maternal anti-BP-AG2 antibodies are responsible for 
skin lesions but also interact with placenta antigens, weakening its 
function. Therefore PG is associated with preterm labor or small-for-
-gestational-age newborns.
material and methods: The 23-year-old woman with epilepsy, at 36th 
week of her second gestation, was admitted to the 1st Department 
of Obstetrics and Gynecology due to the presence of severe pruritus, 
serous subepidermal bullae and weak fetal movements. Up to 35th 
week the course of pregnancy was uncomplicated and the patient 
did not require antiepileptic therapy. On examination fresh bullous 
lesions along with old healed scar marks on the abdomen and limbs 
were observed. After dermatological consultation PG was diagnosed. 
Topical corticosteroids and antipruritic drugs were introduced with 
good clinical effect. No abnormalities in cardiotocograms or ultrasound 
scan were detected. However, due to the nature of the disease labor 
induction was performed at 37 week of gestation. Due to the signs of 
imminent fetal asphyxia cesarean section was performed. A healthy 
male newborn weighting 3290 g without any skin lesions was born. Few 
days later the mother and her child were discharged home in a good 
general condition.
Conclusions: As PG may be associated with adverse pregnancy out-
comes, a multidisciplinary approach with an appropriate pharmaco-
therapy and close fetal monitoring is required. 
coexiStence of bullouS pemphigoid and dermatitiS 
herpetiformiS — a rare caSe report
Aleksandra Hoffmann, Aleksandra Pogoda
Studenckie Koło Naukowe przy Katedrze i Klinice Dermatologicznej, 
Warszawski Uniwersytet Medyczny
trustee of the paper: Patrycja Gajda
introduction: Dermatitis herpetiformis (DH) and bullous pemphigoid 
(BP) are bullous autoimmune diseases of the skin microscopically cha-
racterized by subepidermal blisters.
material and methods: A 64-year-old man presented with dissemi-
nated erythematous papules, tense blisters and erosions on the trunk, 
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buttocks, extremities and scalp with concomitant persistent pruri-
tus. First lesions have already developed a year before and since then had 
increased in number. Direct immunofluorescence examination revealed 
linear deposition of IgG IgM at the basement membrane zone as well as 
granular deposits of IgA, IgM and IgG in the papillary dermis. Indirect 
IMF detected circulating anti-BMZ IgG at a titer of 1:5 with epidermal 
binding on salt-split skin. Histopathological examination of a skin lesion 
showed a marked necrosis of the epidermis, interstitial dermis edema 
with scattered eosinophils. Dapsone, doxycycline, topical clobetasol 
propionate and a gluten-free diet were initiated. A partly resolution 
of the skin lesions and significant reduction of pruritus was achieved. 
Conclusions: There are only a few cases in the literature describing 
concomitance of dermatitis herpetiformis and bullous pemphigoid. The 
etiological and pathogenetic processes that cause this rare coexistence 
are not fully understood. Further studies are needed to elucidate the 
pathogenesis of these bullous diseases.
dermoScopy of darier’S diSeaSe
Dominika Siemianowska, Aldona Babiarz
Studenckie Koło Naukowe przy Katedrze i Klinice Dermatologicznej, 
Warszawski Uniwersytet Medyczny
trustee of the paper: Marta Sar-Pomian, Agata Szykut 
introduction: Darier’s disease is an autosomal dominant genodermato-
sis characterised by hyperkeratotic papules occasionally accompanied 
by pruritus. This condition is usually diagnosed on the basis of clinical 
picture and histopathological examination. We present a case of Darie-
r’s disease along with dermoscopic findings to show the usefulness of 
this method in non-invasive diagnosis of this condition.
material and methods: A 20-year-old man presented with a 5-year 
history of keratotic follicular papules localized on the upper chest 
and the neck. Nails abnormalities, such as split and thinning of the 
distal parts of the finger nail plates were observed. Dermoscopy of 
the skin lesions revealed polygonal, star-like or roundish-oval-shaped, 
yellowish-brownish areas surrounded by a whitish halo localized on 
a pinkish homogeneous background. The onychoscopy showed red 
and white longitudinal bands and characteristic “V-shaped notch”. The 
histopathology of the skin lesion showed acantholysis, parakeratosis 
and dyskeratosis with characteristic corps ronds and grains which was 
consistent with Darier’s disease. The patient was initially treated with 
systemic acitretin which was substituted with oral isotretinoin due to 
increased hair loss and skin dryness. A major improvement of skin lesions 
was observed after one month.
Conclusions: Our case report illustrates the importance of dermoscopy 
in the early diagnosis of Darier’s disease. Its dermoscopic picture differs 
from bacterial folliculitis and seborrheic dermatitis, which are main 
differential diagnoses of Darier’s disease. Furthermore, Darier’s disease 
has also specific onychoscopic picture. In conclusion, dermoscopy of 
skin and nails can be regarded as a useful non-invasive tool in the 
diagnosis of Darier’s disease.
dermoScopic featureS of familiar angiokeratoma
Martyna Wilk, Monika Krzywda
Studenckie Koło Naukowe przy Katedrze i Klinice Dermatologicznej, 
Warszawski Uniwersytet Medyczny
trustee of the paper: Anna Woźniak-Rito 
introduction: The term angiokeratoma refers to vascular skin lesions that 
appear as black-red papules and plaques, separate or arranged in clu-
sters. Although the etiopathology is still unknown, genetic predisposition, 
pregnancy and trauma could be the main causal factors. Five clinical forms 
of angiokertomas have already been described in literature. The aim of this 
study was to analyze a dermoscopic pattern of angiokeratoma diagnosed 
at the Department of Dermatology at Medical University of Warsaw.
material and methods: The case concerned a histologically confirmed 
angiokeratoma in a 53-year-old female with a 28-year history of a 10-cm 
vascular malformation consisting of black papules on the left buttock. 
The first lesion appeared during pregnancy. Similar vascular malforma-
tions were present on her father’s skin. Dark and red lacunae, a whitish 
veil and peripheral erythema have been observed dermatoscopically. 
The patient has been scheduled for a laser therapy.
Conclusions: Several dermoscopic structures of pregnancy — induced 
angiokeratoma with a family history have been identified. Usually a cli-
nical diagnosis of angiokeratoma is sufficient but the presence of red and 
dark lacunae with whitish veils could help to differentiate pigmented 
lesions such as melanomas and other vascular structures from angio-
keratoma under dermoscopic examination. 
dermatoScopic examination of extragenital lichen 
ScleroSuS
Monika Świderska, Aleksandra Woźnica 
Studenckie Koło Naukowe przy Katedrze i Klinice Dermatologicznej, 
Warszawski Uniwersytet Medyczny
trustee of the paper: Anna Woźniak-Rito
introduction: Lichen sclerosus (LS) is chronic, inflammatory skin disease 
of unknown etiology. The peak incidence occurs between 50−60 years of 
age and in majority of cases it affects women. It is usually located in the 
anogenital region and is accompanied by severe pruritus, easy bleeding, 
pain and dysuria. Extragenital location of LS in areas such as shoulders 
or trunk is more uncommon and usually remains asymptomatic. Por-
celain-white papules which demonstrate a tendency to coalesce into 
bigger patches with follicular hyperkeratosis are characteristics of the LS. 
There are only few descriptions of dermatoscopy of LS in the literature.
material and methods: A 58-year-old woman presented with LS lo-
cated on the trunk, in the inguinal region, on the labia majora as well 
as vulval mucosa. The first lesions appeared about 3 years ago and 
gradually increased. In the diagnostic process both histopathological 
and dermatoscopic examinations of extragenital lesions were used 
and correlated. Dermatoscopy revealed white structureless areas, thin, 
sharply branching telangiectasias of different length, yellowish circles 
and multiple small black dots. White structureless areas corresponded 
to dermal sclerosis, yellowish circles to follicular plugging and multi-
ple small dots to scattered melanophages indicative of the resolved 
interface dermatitis.
Conclusions: Growing popularity of dermatoscopic examination arises 
the possibility of application of this method in LS. Evaluation of more 
cases will allow to determine to what extent the dermatoscopic image 
corresponds to histopathological findings and disease activity. It could 
be tempting to consider dermatoscopy as potential method of choice 
in LS diagnosis in the future.
drug-induced cutaneouS lupuS erythematoSuS  
— a deScription baSed on a caSe preSentation
Marko Broma, Małgorzata Maj, Joanna Czuwara
Studenckie Koło Naukowe przy Katedrze i Klinice Dermatologicznej, 
Warszawski Uniwersytet Medyczny
trustee of the paper: Małgorzata Maj, Joanna Czuwara
introduction: Some medications may induce an autoimmune response 
leading to the development of drug-induced lupus erythematosus 
(DILE) or subacute cutaneous lupus erythematosus (SCLE).
material and methods: We present a case of 82-year-old Cauca-
sian man receiving treatment for Hodgkin’s lymphoma (COP regimen 
of chemotherapy: cyclophosphamide, vincristine, prednisone) and 
propafenone and bisoprolol on a regular basis. The patient developed 
the manifestations after introduction of allopurinol which occurred two 
weeks after completing the second course of chemotherapy. Cutaneous 
erythemato-edematous and erythemato-exfoliative lesions occurred in 
a photodistributed pattern along with the commencement of allopu-
rinol administration. Laboratory tests showed circulating antinuclear 
antibodies (Ro antibodies at a titer of 1:640) and slight leukocytosis 
(12 040/mm3) with elevated lymphocyte and monocyte count. Skin 
biopsy showed lesions at the dermo-epidermal junction character-
istic of SCLE or adverse drug reaction. Direct immunofluorescence 
(DIF) of non-lesional skin from the lesional edge showed granular IgG 
deposits. Discontinuation of allopurinol and introduction of systemic 
treatment with systemic and topical corticosteroids resulted in the 
resolution of active cutaneous lesions. However, post-inflammatory 
discoloration remained on the skin.
Conclusions: It is unknown whether the disease was drug-induced or 
related to systemic diseases — Hodgkin’s lymphoma and its treatment. 
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A full clinical picture of the patient, histopathological findings and DIF 
do not provide an unambiguous diagnosis. The patient met the criteria 
of SCLE diagnosis as well as adverse drug reaction. Taking into consid-
eration that both drug-induced SCLE and DILE might be provoked by 
many medications from different therapeutic groups, the awareness of 
mentioned diseases is crucial while diagnosing skin lesions.
clinical, dermoScopic and hiStological 
characteriSticS of mammary paget’S diSeaSe and nipple 
eczema — the Study of two caSeS
Anna Zaryczańska1, Martyna Sławińska1, Joanna Lakomy2,  
Aleksandra Rosiak-Buller1, Małgorzata Sokołowska- Wojdyło1,  
Wojciech Biernat2, Roman Nowicki1, Michał Sobjanek1 
1Studenckie Koło Naukowe przy Klinice Dermatologii, Wenerologii 
i Alergologii, Gdański Uniwersytet Medyczny
 2Katedra i Zakład Patomorfologii, Gdański Uniwersytet Medyczny
trustee of the paper: Michał Sobjanek
introduction: Paget’s disease is a distinct, rare subtype of breast cancer. 
It clinically presents as an unilateral erythema with associated vesicles 
and erosions or scaling. The main differential diagnosis is nipple eczema, 
which occurs more commonly. The final diagnosis is made based on 
histopathological examination.
material and methods: We report the cases of two female patients 
(19- and 43-year-old) who presented to Department of Dermatology, 
Venerology and Allergology Medical University of Gdańsk with unilateral 
erythematous lesion on the breast. In both cases clinical and dermo-
scopic assessment was performed. The histopathological examination 
revealed the features of nipple eczema and mammary Paget’s disease, 
respectively.
Conclusions: Based on authors’ observation it seems that dermoscopic 
presentation of nipple eczema and mammary Paget’s disease is different. 
We have found only one case report describing dermoscopic features 
of non-pigmented mammary Paget’s disease. The future studies are 
needed to establish the role of dermoscopy in this area.
what not to miSS in anogenital region? a caSe of 
extramammary paget’S diSeaSe
Aleksandra Papiewska, Aleksandra Pełka
Studenckie Koło Naukowe przy Katedrze i Klinice Dermatologicznej, 
Warszawski Uniwersytet Medyczny
trustee of the paper: Anna Woźniak-Rito, Joanna Czuwara
introduction: Extramammary Paget’s Disease (EMPD) is a rare intraepi-
thelial adenocarcinoma, which predominantly affects postmenopausal, 
female patients. It targets cutaneous areas that are rich in apocrine 
glands. The most common location is the vulva, followed by the perianal 
or genital region. Clinical diagnosis must be confirmed by histopatho-
logy that reveals the presence of typical Paget cells. 
material and methods: A 54-year-old male patient presented to the 
Department of Dermatology with an erythematous — desquamative 
patch in a suprascrotal area with a minor scrotal skin involvement. 
The lesion was approximately 5cm in diameter, sharply demarcated 
and appeared a year before. The patient denied allergic diseases and 
family history of psoriasis. Empirically initiated antifungal treatment 
was not effective and properly carried out mycological examination 
excluded fungal infection. Videodermoscopy revealed a polymor-
phous vessel pattern with prominent irregular linear, glomerular 
and dotted vessels. Additionally structureless white-pink areas were 
present. Subsequently a biopsy was performed with a suspicion of 
Bowen disease based on clinico-dermoscopical correlation. Histo-
pathological findings were characteristic for extramammary Paget 
disease. The patient was consulted surgically and first treated with 
5% topical imiquimod. 
Conclusions: Differential diagnoses of EMPD include: Bowen’s disease, 
fungal infection, eczema and psoriasis. Every skin lesion in anogenital 
area, that is unresponsive to treatment, should be suspected for EMPD 
regardless the gender. Dermoscopy may be helpful in diagnostic pro-
cess of EMPD.
endovaScular management of neck Skin cancer leSion 
bleeding
Mateusz Kaczmarski, Wojciech Gług 
Studenckie Koło Naukowe przy Oddziale Chirurgii Ogólnej, Naczyniowej 
i Onkologicznej w Międzyleskim Szpitalu Specjalistycznym w Warszawie
trustee of the paper: Radosław Kowalewski
introduction: Skin cancer progression during palliative treatment 
can lead to arteries infiltration and uncontrolled hemorrhage from 
skin cancer lesion, that can be fatal to the patient.
material and methods: A 80-year-old patient with skin cancer of neck 
and right supraclavicular region after palliative radiotherapy was ad-
mitted to hospital because of the bleeding from one of cancerous 
ulceration in the neck region. After initial haemostasis and stabilizing 
the patient, arteriography of aortic arch was performed. It visualized 
branching of right subclavian artery which were supplying cancerous 
lesions and caused bleeding. Covered stent was implanted in right 
subclavian artery occluding its branches with preserved patency of 
vertebral artery. Patient was discharged from hospital 3 days after 
procedure, post-operative recovery was uneventful.
Conclusions: Hemorrhage caused by cancerous skin lesions can be treat-
ed using endovascular approach. Implanting endovascular prosthesis 
occluding pathological vessels can minimize risk of recurrence of bleeding. 
Further studies are needed to evaluate long-term effects of such approach.
diSSeminated granuloma annulare coexiSting with 
neoplaSm in two patientS — relationShip or coincidence? 
Wiktor Orlof, Paulina Kossakowska, Julia Nowowiejska,  
Joanna Bacharewicz-Szczerbicka, Anna Baran, Iwona Flisiak
Studenckie Koło Naukowe przy Klinice Dermatologii i Wenerologii, 
Uniwersytet Medyczny w Białymstoku 
trustee of the paper: Anna Baran
introduction: Granuloma annulare (GA) is a chronic granulomatous 
dermatosis of unclear etiopathology with an estimated incidence of 
0.1−0.4%. Generalized GA has been associated with systemic diseases 
but also malignant neoplasms.
material and methods: CASE 1: A 58-year-old patient was admitted due 
to the 7-month history of multiple disseminated, red papules and erythe-
matous plaques on the neck, trunk and upper limbs. After 2 months 
of the onset of them the metastases to lymph nodes of squamous cell 
carcinoma of unknown origin were diagnosed. The histopathological 
examination confirmed GA. After skin biopsy regression of the lesions 
occured. CASE II: A 59-year-old man with diagnosed one month earlier 
laryngeal squamous cell carcinoma was admitted due to the 8 years 
history of numerous disseminated papules on the trunk, upper and 
lower limbs. The histopathological examination revealed GA.
Conclusions: Generalized granuloma annulare concerns 9−15% of 
patients with GA and might be associated with systemic diseases or 
malignancy. The primary skin lesions are often non-specific, with aty-
pical location. The presented cases emphasize the need for diagnostic 
examinations for cancer in patients with generalized GA.
when to think about acrodermatitiS chronica 
atrophicanS? 
Adam Włodarczak, Justyna Ceryn
Studenckie Koło Naukowe przy Katedrze i Klinice Dermatologicznej, 
Warszawski Uniwersytet Medyczny
trustee of the paper: Joanna Czuwara, Anna Waśkiel, Alicja Kryst
introduction: Acrodermatitis chronica atrophicans (ACA) is a late ma-
nifestation of borreliosis mainly located on extremities. It begins with 
inflammatory stage characterized by bluish red discoloration and cutane-
ous swelling. Two cases of ACA with various presentation are presented. 
material and methods: 29-year-old woman was suspicious of connec-
tive tissue disease presenting with Raynaud’s phenomenon for eight 
years and violaceous discoloration on the left buttock, both knees 
and left foot for seven years. At admission, fingers and extensor part 
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of her left hand were also reddish. Patient denied arthritis, loss of hair, 
erosion of the mucosal membrane and decreased exercise tolerance. In 
serological tests: ANA(-), ACA(-), lupus antibody(-), cryoglobulin(-), RF(-), 
ANCA(-). ELISA for B. burgdorferi IgG was positive and IgM negative. 
Venous ultrasound was unremarkable. DIF from her left leg was negative. 
Histological examination of the biopsy from her buttock demonstrated 
multiple dilated blood vessels, perivascular and interstitial inflamma-
tion containing many plasma cells and focally thickened collagen fi-
bers characteristic of acrodermatitis chronica atrophicans. 59-year-old 
woman with a two year history of erythema on the extensor surface of 
her right hand treated as contact dermatitis without any improvement. 
Digital joints were edematous. Rheumatic diseases were excluded. Skin 
biopsy of the right hand was characteristic for acrodermatitis chronica 
atrophicans. ELISA to Borrelia IgG was positive. The woman was treated 
with oral doxycyclin with a good response. 
Conclusions: ACA has to be considered in any case of acral asym-
metric, red-violaceous discoloration of skin with visible vasculature. 
The diagnosis must be confirmed by combining clinical, serologic and 
histopathological results.
adalimumab — Safe and effective therapy for 
pediatric patient with Severe pSoriaSiS and immune 
thrombocytopenia
Magdalena Chrabąszcz, Mariusz Sikora
Studenckie Koło Naukowe przy Katedrze i Klinice Dermatologicznej, 
Warszawski Uniwersytet Medyczny
trustee of the paper: Mariusz Sikora
introduction: Psoriasis is a cutaneous, chronic inflammatory disorder 
that affects approximately 4% of adults and up to 2% of children world-
wide. Early onset during childhood or adolescence has a significant 
impact on the quality of life. Pediatric psoriasis may be associated with 
various comorbidities, including metabolic syndrome, atopy, celiac 
disease and alopecia areata. Immune thrombocytopenia is one of the 
most common acquired bleeding disorders in children that is developed 
secondary to the production of auto-antibodies against platelets. The as-
sociation of immune thrombocytopenia and psoriasis has been reported 
rarely. Due to potential platelet-lowering effect of immunosuppressive 
drugs, systemic treatment of pediatric psoriasis coexisting with immune 
thrombocytopenia is a real clinical challenge.
material and methods: We present a case of 17-year-old girl with 
immune thrombocytopenia and severe plaque psoriasis. The patient 
was previously treated with PUVA therapy, acitretin (0.5 mg/kg bw/day), 
methotrexate (20 mg/week) and cyclosporine (3.5 mg/kg bw/day) but 
she never obtained a clinically meaningful response. At the time of 
admission to our Department psoriasis area severity index (PASI) score 
was assessed at 34.9 and body surface area: 48%. The patient received 
adalimumab, a human anti-TNF monoclonal antibody, 40 mg subcuta-
neously every 2 weeks.         
A rapid improvement was seen after first two injections, with almost 
complete remission during the following weeks. During biologic therapy 
we did not observe any adverse events. The platelet count moderately 
increased.
Conclusions: Psoriasis and immune trombocytopenia are quite com-
mon in pediatric population, but their coexistence is rare. Altered TNF 
expression could be a pathogenic linkage and therapeutic target for 
these diseases. 
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PSoriaSiS vulgariS and endocrine diSorderS  
— a ProBlematiC relationSHiP
Miłosz Matałowski, Aleksandra Papiewska
ENDOCRINUS, Studenckie Endokrynologiczne Koło Naukowe, Warszawski 
Uniwersytet Medyczny
trustee of the paper: Aleksander Kuś
Psoriasis vulgaris (PV) is an autoimmune disease characterized by hyper-
proliferation of keratinocytes, which can significantly reduce the quality 
of life. A number of exogenous and endogenous factors is known to 
induce or exacerbate the course of PV. Among the potential endogenous 
triggering factors, there can be found various disorders of endocrine 
system. Here we present the most important correlations between 
hormonal dysfunctions and PV. Stress hormones, like cortisol and epi-
nephrine, exert pleiotropic effects on both, immune system and skin. 
Comparing to healthy controls, patients with PV tend to present higher 
levels of epinephrine and lower levels of cortisol. Cortisol deficiency 
promotes inflammatory responses in keratinocytes. Also sex hormones 
may play an important, but still unclear, role in the pathogenesis of PV 
since many studies have demonstrated the anti-inflammatory effects 
of estrogens. 
On the other hand, estrogens stimulate keratinocytes proliferation 
and angiogenesis which can potentially induce the development of 
PV. It has been reported that also prolactine (PRL) and growth hor-
mone (GH) have an immunostimulative activity which can promote the 
development of PV. They may induce keratinocytes proliferation and 
angiogenesis as well. While patients with prolactinoma often present 
symptoms of PV, it has been suggested that bromocriptine, which de-
creases PRL levels, can also reduce the severity of PV symptoms. Finally, 
thyroid hormones may be involved in the pathogenesis of PV as they 
affect proliferation and differentiation of the skin cells. However, the 
results of the studies on this issue are highly inconsistent and require 
further confirmation.
the role of vitamin d3 in the treatment of pSoriaSiS 
Zuzanna Kozłowska, Gabriela Zdunek
Studenckie Koło Naukowe przy Katedrze i Klinice Dermatologicznej, 
Warszawski Uniwersytet Medyczny
trustee of the paper: Magdalena Misiak-Gałązka, Karolina Kozera
In this study we aimed at determining the impact of vitamin D3 on the 
psoriatic patients. Vitamin D3 is a steroid hormone, converted in the 
skin from 7-dehydrocholesterol to cholecalciferol by the UV irradiation. 
An active form of vitamin D3 (calcitriol or 1.25[OH]2D3) is formed in 
further reactions. It binds to a nuclear receptor-VDR, located in the skin 
cells. By that, the expression of over 900 significant genes is regulated. 
Vitamin D3 and its analogs influence proteins (p21 and p27) and enzy-
mes (CDKs) that participate in the cell cycle. Consequently, they control 
proliferation, differentiation and apoptosis of keratinocytes. Moreover, 
vitamin D3 modulates the immune response and regulates cathelicidin 
antimicrobial peptide production. It is also suggested that calcitriol 
and its metabolites play a role also in the photoprotection and have 
anti-cancer activity. The vitamin is widely used in the psoriasis tre-
atment due to its antiproliferative and pro-differrentiative effects 
on epidermal cells. It has anti-inflammatory activity, for example, in 
suppressing IL-2 gene transcription. Additionally, vitamin D3 inhibits 
the increased synthesis of cathelicidins, which contribute to self-DNA 
aggression in psoriasis. Taking into consideration its effects, vitamin 
D3 and its analogs, in particular calcipotriol and tacalcitol have been 
implemented in practice. The vitamin D3 therapy focuses mainly on 
topical treatment which stimulates the immune tolerance using Tregs. 
Phototherapy, for instance PUVA increases the level of 25-hydroxyvita-
min D in the skin, and both this treatment and oral supplementation 
with vitamin D3 may be used and were examined in this study.
the gut-Skin connection. how gut microbiome affectS 
the development of pSoriaSiS and pSoriathic arthritiS?
Aleksandra Pohadajło
Studenckie Koło Naukowe przy I Klinice i Katedrze Położnictwa i Ginekologii, 
Warszawski Uniwersytet Medyczny
At the recent time the scientific society has gained an insight into the 
importance of the intestinal resident flora for the host’s health and 
disease. In fact a gut microbiota plays an essential role in modulating 
innately and acquiring immune responses, thereby has an influence 
on the balance of inflammation and tolerance. The fact that both the 
gut and the skin engage in the connections goes back to the first half 
of the 20th century, notably to the dermatologist Stokes and Pillsbury. 
Nowadays aspects of this theory have been further proven by modern 
scientific investigations.
Psoriasis is a common immune-mediated chronic inflammatory skin 
disease and about 30% of people with psoriasis also develop a form of 
inflammatory arthritis ca lled psoriatic arthritis. The pathogenesis of the 
diseases haven’t been fully understood — Th17 cells and the cytokines 
they produce, such as IL-17, IL-22 and IL-23, play a critical role in the 
pathogenesis of psoriasis. Gut microbiota, as the modulating factor of 
an immune response, can influence on the development and patho-
genesis of psoriasis and psoriatic arthritis. The aim of this review is to 
present the recently investigated role of a gut microbiome in psoriasis 
and psoriatic arthritis.
ColoStrum Bovinum Supplementation in the 
treatment of pSoriaSiS
Maja Czerwińska, Joanna Hołowko, Natalia Komorniak, Joanna Palma
Pomorski Uniwersytet Medyczny w Szczecinie
trustee of the paper: Ewa Stachowska
Psoriasis vulgaris is a chronic inflammatory disease that primarily affects 
the skin. The typical areas of the body with skin lesions are elbows, knees 
and scalp, but skin patches may be found on any part of the skin. Psor-
iasis is linked to depression, social stigmatization and pain. The patho-
genesis of psoriasis is still unknown, but some studies suggest that this 
disease is mediated by Th1 lymphocytes. We also know that psoriat-
ic lesions are characterized by the infiltration of T lymphocytes. Bovine 
colostrum is the first milk produced by cows during the first days post-
parturition. It contains immunoglobulins and growth factors such as 
the insulin-like growth factor (IGF) or the epidermal growth factor (EGF) 
as well as pro-inflammatory cytokines such as interleukin-1β, interleu-
kin-6, TNF-α and interferon-γ. The available studies suggest a beneficial 
effect of supplementation of bovine colostrum in immune-deficiency 
syndromes. Some studies suggest that bovine colostrum may suppress 
Th1 immune response and down-regulate the activity of infiltrated 
T-cells. Further research is needed to confirm the positive therapeutic 
effect of bovinum colostrum in patients with psoriasis.
SKin equivalent oF HPa axiS and itS role 
in PatHogeneSiS of pSoriaSiS
Katarzyna Górska
Studenckie Koło Naukowe przy Katedrze i Klinice Dermatologicznej, 
Warszawski Uniwersytet Medyczny
trustee of the paper: Joanna Czuwara
In response to stress factors such as chemical or mechanical injury, expo-
sure to UVB radiation or infection, skin expresses all crucial elements of 
hypothalamus-pituitary-adrenal axis neuroendocrine system: corticotro-
pin-releasing hormone (CRH), ACTH and glucocorticosteroids, especially 
cortisol. The biosynthesis of steroid hormones begins with mobilization 
of cholesterol from cellular stores to the mitochondrial inner membrane, 
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where CYP11A1 constitutively converts it into pregnenolone. Increased 
provision of cholesterol by StAR protein leads to a corresponding rise in 
the rate of pregnenolone production. The locally produced pregneno-
lone undergoes further transformation to glucocorticosteroids. Besides 
the complete set of enzymes necessary for steroidogenesis, the skin also 
expresses 11βHSD1, which activates cortisol from inactive cortisone, 
and 11βHSD2 that works in the opposite direction. The expression 
and activity of the two forms of 11βHSD vary within the localization 
of the skin, changes with aging and can be modified by the action of 
pharmaceutical agents. The concept of deficient endogenous gluco-
corticosteroidogenesis affecting cutaneous immunity as an important 
factor in pathogenesis of psoriasis has been verified and validated by 
Hannen et al. (2017). The researchers detected very low concentrations 
or even absence of StAR protein and reduced expression of CYP11A1 in 
skin lesions. Expression of 11βHSD 1 and 2 was significantly decreased 
in skin lesions. It was assessed that psoriatic keratinocytes synthesized 
de novo substantially less cortisol than healthy keratinocytes. Glucocor-
ticoid receptor expression was also diminished. It has been suggested 
that restoration of local glucocorticoid signaling system might be a new 
therapeutic approach for psoriasis treatment.
DuPilumaB — a BreaKtHrougH in tHe treatment 
oF atoPiC dermatitiS?
Małgorzata Rykowska, Mariusz Sikora
Studenckie Koło Naukowe przy Katedrze i Klinice Dermatologicznej, 
Warszawski Uniwersytet Medyczny
trustee of the paper: Mariusz Sikora 
Atopic dermatitis is among the most common inflammatory skin di-
seases in children and adults. The disease poses a significant burden 
on health-care resources and patients’ quality of life. Therefore, there is 
a large unmet need for safe and effective therapeutics for this condition. 
Over the last few years, new advances in the understanding of pathophy-
siological mechanisms in atopic dermatitis have led to the identification 
of specific therapeutic targets. Dupilumab, a fully human monoclonal 
antibody, is directed against IL-4 receptor alpha subunit. It blocks the 
signaling pathways of key Th2 cytokines — IL-4 and IL-13. In March 
2017, the US FDA approved dupilumab for the treatment of moderate 
to severe atopic dermatitis in adults not adequately controlled by topical 
therapy. The approval was based on the results of three randomized 
trials (SOLO 1 and 2, LIBERTY AD CHRONOS). They showed significant 
reduction in atopic dermatitis activity assessed by the most frequently 
used disease-severity instruments (EASI, IGA and SCORAD). Dupilumab 
was also associated with improvement in pruritus, sleep and quality of 
life. The medication is administered as a subcutaneous injection, with 
an initial dose of 600 mg followed by 300 mg every two weeks. The most 
common reported adverse effects have included ocular symptoms (con-
junctivitis, blepharitis, keratitis, xerophthalmia, pruritus), herpes simplex 
virus infections and injection site reactions. The efficacy of dupilumab 
confirmed the pivotal role of IL-4 and IL-13 in the pathogenesis of atopic 
dermatitis. This biologic seems to be a long-awaited breakthrough in 
the treatment of atopic dermatitis.
miCronutrientS — undereStimated factorS in 
development and treatment oF aloPeCia areata? 
Magdalena Cichowska, Anna Waśkiel
Studenckie Koło Naukowe przy Katedrze i Klinice Dermatologicznej, 
Warszawski Uniwersytet Medyczny
trustee of the paper: Anna Waśkiel
Alopecia areata is an autoimmune form of non-scarring alopecia that 
can affect any hair-bearing area. The frequency of the disease ranges 
from 0.7% to 3.8% of patients attending dermatology clinics. Although 
the exact pathogenesis of alopecia areata remains to be clarified, gene-
tic predisposition, autoimmunity and environmental factors have been 
discussed. Furthermore, it has been hypothesized that deficiency of 
micronutrients may represent a modifiable risk factor associated with 
development of the disease. The aim of this review is to present the 
role of micronutrients in alopecia areata. A systematic review of the 
literature was performed by searching the PubMed and complemented 
by a thorough hand search of reference lists. All of the selected articles 
were published in English, with the first one dating from 1981. Com-
pared to controls, patients with alopecia areata were found to have 
a decreased serum concentration of vitamin D, zinc and folate. It has 
also been observed that too low or too high level of vitamin A may 
favor the development, maintenance, or progression of alopecia areata 
in mice. The role of vitamin B12, copper, magnesium and selenium in 
pathogenesis of alopecia areata remains equivocal, because previously 
reported studies presented insufficient or conflicting data. In conclu-
sion, micronutrients may have influence on pathogenesis of alopecia 
areata. However, more large-scale prospective studies are needed to 
confirm the role of micronutrients in pathogenesis of alopecia areata 
as well as effectiveness of micronutrient supplementation in treatment 
of the disease.
aloPeCia aS a Symptom in HaSHimoto’S DiSeaSe anD 
otHer tH-17 lymPHoCyte relateD autoimmune 
DiSeaSeS
Martyna Torz, Katarzyna Wójcik
Studenckie Koło Naukowe przy Katedrze i Klinice Dermatologicznej, 
Warszawski Uniwersytet Medyczny
trustee of the paper: Anna Skrok
Th-17 cells play a role in adaptive immunity protecting human organism 
from pathogens. They are also implicated in autoimmune and inflam-
matory disorders. It has been proven that their overactivation can cause 
an inappropriate amount of systemic inflammation and leads to nu-
merous inflammatory-related disorders such as Hashimoto’s disease, 
multiple sclerosis, diabetes mellitus  type 1 (DM1), psoriasis. In patients 
with autoimmune Th-17 lymphocyte-related diseases a chronic telogen 
effluvium is observed more often than in general population. Moreover, 
a single patient can be often diagnosed with multiple autoimmune 
diseases also with autoimmune special type of hair loss — alopecia 
areata (AA). The involvement of Th-17 cells has also been shown in aller-
gen-specific immune responses and is associated with the severity of AD. 
In our review we will focus on alopecia  among patients suffering from 
Th-17 lymphocyte-related diseases (autoimmune diseases) and show 
the correlation between hair loss and changes of immunity.
the role of fractional co2 laSer in the treatment of 
neoplaStic Skin leSionS
Paulina Strugała, Ewa Wydrzyńska
Studenckie Koło Naukowe przy Katedrze i Klinice Dermatologicznej, 
Warszawski Uniwersytet Medyczny
trustee of the paper: Jacek Szymańczyk
Advances in laser technology in recent decades have increased the 
options for the treatment of dermatologic conditions. Lasers may be 
an alternative for surgical excision and other forms of therapy. Among 
many laser types, the carbon dioxide (CO2) laser remains an important 
system for the dermatologist. Carbon dioxide laser ablation can be 
used safely with good cosmetic outcome and low recurrence rate. 
This study has demonstrated a potential role of using of laser the-
rapy in the treatment of benign skin tumors. Based on the reviewed 
literature, laser treatment has generally been proven to be a safe 
and effective therapy for some benign skin neoplasm with minimal 
side effects. The group of indications regarding benign tumors and 
organoid nevi is very heterogeneous. For these indications, patients 
often search help for cosmetic reasons. Despite their benign nature, 
many of these neoplasms cause aesthetic or symptomatic distress and 
require removal. Ablational laser systems are established treatment 
devices for benign skin tumors. They obtain good cosmetic results 
with mostly minimal side effects. As laser technology continues to 
advance, we are sure to see improvements in current treatments, as 
well as development of new applications of cutaneous lasers. Review 
of the literature demonstrates the progress of dermatological under-
standing of the clinical implications of laser therapy in the treatment 
of neoplasms of the skin.
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dreSS Syndrome: pathogeneSiS, clinical preSentation 
and treatment
Ewa Tenderenda
Studenckie Koło Naukowe przy Katedrze i Klinice Dermatologicznej, 
Warszawski Uniwersytet Medyczny
trustee of the paper: Marta Sar-Pomian
The Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) 
is a rare, potentially life-threatening drug-induced hypersensitivity reac-
tion. It is frequently caused by allopurinol and antiepileptic drugs. The 
pathogenesis of DRESS is not fully understood. A key factor is a drug-
-specific immune response, occurring in genetically predisposed per-
sons. Reactivation of several viruses may also play a role in this condition. 
DRESS can be characterized with widespread skin lesions, typically with 
maculopapular rash, which can turn into erythroderma, accompanied by 
fever. Hematologic abnormalities (eosinophilia, atypical lymphocytosis), 
lymphadenopathy and internal organ involvement (such as liver, kidney, 
lungs, heart, central nervous system involvement) can occur. A long 
latent period after intake of the inciting drug and a prolonged and 
protracted clinical course is typical. The diagnosis of DRESS is challenging 
because the pattern of cutaneous eruption and the types of organs 
involved are various. The main management of DRESS is withdrawal of 
the culprit drug. Topical and, in severe cases, systemic corticosteroids 
can be used. Most patients with DRESS recover completely in weeks to 
months after drug withdrawal.
Skin manifeStationS of gluten intolerance
Anna Przeździak, Zuzanna Sitkowska
Studenckie Koło Naukowe przy Katedrze i Klinice Dermatologicznej, 
Warszawski Uniwersytet Medyczny
trustee of the paper: Joanna Misiewicz-Wroniak
Dermatitis herpetiformis is a chronic bullous disease of the skin, which 
is considered as a skin manifestation of gluten intolerance. It is the most 
common in 20−40 year old people, more often in men than women. 
It is characterised by polymorphous lesions, localized symmetrically, 
especially on the elbows, knees and in the lumbar area with intense 
burning and itching. 80−90% cases of DH in the Caucasian race are 
connected with the genotypes HLA DR3 and HLA DQw2, whereas in 
the Mongoloid race — with the genotypes HLA Cw3, HLA A2 and HLA 
DR9. In people affected by DH we can observe granular IgA deposits in 
the dermal papillae, both in involved and uninvolved skin. In the blood 
serum they are detectable specific antibodies gainst transglutaminase 
autoantigens and also against endomysium, gliadin and reticuline. In 
diagnosis of DH we may use direct and indirect immunofluorescence, 
ELISA and dermatoscopy. The treatment of choice consists of dapsone 
and a strict gluten-free diet. There are also atypical forms of dermatitis 
herpetiformis, which we describe in this paper. Nowadays more and 
more another diseases of the skin and mucous membrane are reported 
as possibly connected with celiac disease or non-celiac gluten intole-
rance. We can divide these conditions into four groups: autoimmune, 
allergic, inflammatory and miscellaneous. In this article we describe 
diseases of the skin and mucous membrane connected with gluten 
intolerance, differentiating them into the illnesses strongly connected 
with gluten intolerance or which connection with gluten intolerance 
is considered controversial.
the uSe of high-doSe intravenouS immunoglobulin in 
dermatology 
Marlena Ćwiklik, Piotr Wierzbowski
Studenckie Koło Naukowe przy Katedrze i Klinice Dermatologicznej, 
Warszawski Uniwersytet Medyczny
trustee of the paper: Marlena Majkut-Sobechowicz
The specimen of immunoglobulins consists of proteins, salts and car-
bohydrates, but it’s major components are antibodies (mainly IgG). 
The mechanism of their action is multidirectional and they affect the 
immune system. Initially intravenous immunoglobulins have been used 
in immune deficiencies and infectious diseases’ treatment. However, 
recently, the indications for the use of IVIG have been extended. They are 
applied in many acute dermatological diseases with severe course when 
skin or internal organs are rapidly involved. The most urgent indication 
in dermatology for intravenous admission of immunoglobulins is toxic 
epidermal necrolysis, which is a life-threatening disease. It has emerged, 
that IVIGs can be also effective in Stevens-Johnson syndrome, acute 
lupus erythematosus, antiphospholipid syndrome, rapidly progressing 
pyoderma gangrenosum, scleromyxedema, autoimmune blistering skin 
diseases, dermatomyositis and folliculitis decalvans. On the basis of the 
European Guidelines and literature review the main dermatological indi-
cations for the use of high dose (2.0 g/kg/cycle or more) of intravenous 
immunoglobulins will be discussed in our presentation, including both 
well-established and rare conditions. Intravenous administration of im-
munoglobulin has been proven to be an effective and safe treatment of 
many dermatological conditions, particularly those of the severe course. 
In toxic epidermal necrolysis, IVIGs significantly improves prognosis, as 
well as in other cases. Additionally, they are well-tolerated and trigger 
mainly mild adverse effects, which can be managed by symptomatic 
medicines. IVIG’s are contraindicated for patients suffering from conge-
nital IgA deficiency, who possess anti-IgA antibodies.
SyStemic photoprotection
Kinga Krzyżyk, Ewa Zapalska
Studenckie Koło Naukowe przy Katedrze i Klinice Dermatologicznej, 
Warszawski Uniwersytet Medyczny
trustee of the paper: Magdalena Misiak-Gałązka
Ultraviolet radiation in sunlight contributes to photoaging and pho-
tocarcinogenesis. It modifies DNA, cellular antioxidant balance, signal 
transduction pathways, immunology, and the extracellular matrix. Some 
oral substances that counteract the effects of ultraviolet radiation were 
identified. Many of these ingredients are phytochemical derivatives that 
include polyphenols and non-polyphenols. The sources of polyphenols 
include: green tea, cocoa, soy, pomegranate, grape, resveratrol, silyma-
rin, genistein and Polypodium leucotomos. 
Polyphenols have antioxidative, anti-inflammatory and immunoprotec-
tive properties. Main flavonoids of Radix Scutellariae are baicalin and 
wogonoside. Enzyme-treated Radix Scutellariae is efficient in preventing 
ultraviolet B-induced photoaging. The non-phenolic phytochemicals 
include: carotenoids, caffeine and sulphoraphances. Drinking large 
amounts of coffee reduces the basal cell carcinoma risk. Dietary fish 
oils that contain omega-3 polyunsaturated fatty acids can minimize 
ultraviolet-induced inflammation, probably because of reducing prosta-
glandin E2 production. The oral retinoids are likely to prevent squamous 
cell carcinomas, basal cell carcinomas and reduce actinic keratoses. It 
is controversial whether exogenous supplementation of non-enzymic 
antioxidants, e.g. vitamin E, C or carotenes is an appropriate way of 
averting photocarcinogenesis. At low doses of ultraviolet radiation, 
oral supplementation of selenium in combination with antioxidant 
vitamins prevents production of sunburn cells. Also, supplementation of 
nicotinamide protects the skin against photo immunosuppression. Anti-
malarial drugs exhibit photoprotective properties due to an unidentified 
mechanism. It is speculated it occurs due to inhibition of inflammatory 
response of keratinocytes, absorption of particular sunlight waves or 
through induction of c-jun transcription. All of these systemic strategies 
have a potential to provide some level of photoprotection.
the Significance of prolactin in dermatology in the 
light of the lateSt reportS
Julia Humelanc, Weronika Pucek
Studenckie Koło Naukowe przy Katedrze i Klinice Dermatologicznej, 
Warszawski Uniwersytet Medyczny
trustee of the paper: Anna Skrok
Prolactin is a pituitary hormone best known for its role as a lactation 
stimulator in the mammary gland and reproduction facilitator in the 
gonads, however it has a variety of other less-known functions in the 
human body. As the prolactin secretion and receptors were found in 
skin and its appendages, the aim of our review is to highlight newly 
discovered aspects of prolactins, role in the etiopathogenesis of der-
matologic diseases. The influence of prolactins’ central and peripheral 
expression in conjunction with the pathogenesis and exacerbations 
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of the disease has been studied in many skin conditions, for example 
psoriasis, lupus erythematosus, extramammary Paget’s disease, alopecia. 
The precise mechanism of prolactin function in the etiopathogenesis 
of skin conditions is still not well-known, however great progress has 
been made in the recent years. Summarizing we believe further re-
search into the role of prolactin in skin disorders could shed some light 
on the pathophysiology of certain skin diseases and could possibly be 
a promising target for new therapeutic strategies.
interleukin-23 inhibitorS in dermatology
Radosław Wołos, Mariusz Sikora
Studenckie Koło Naukowe przy Katedrze i Klinice Dermatologicznej, 
Warszawski Uniwersytet Medyczny
trustee of the paper: Mariusz Sikora 
The rapid development of new immunomodulatory monoclonal anti-
bodies provides opportunity to selectively target pathogenetic mecha-
nisms in inflammatory skin diseases.
Interleukin 23 (IL-23)/T-helper 17 (Th17) immune axis has been identified 
to play a crucial role in the pathogenesis of psoriasis and other inflam-
matory dermatoses. IL-23 is a heterodimer composed of a p40 subunit 
also found in IL-12 and a p19 subunit exclusive to IL-23. Ustekinumab 
was the first biological IL-23 targeted agent approved in 2009 for the 
treatment of moderate-to-severe plaque psoriasis in adults. It is a fully 
human, monoclonal antibody that binds to the p40, thus preventing 
the interaction between IL-12, IL-23 and their receptors. 
Novel molecules — guselkumab, tildrakizumab and risankizumab, 
directed specifically against p19 subunit of IL-23, are considered to 
be more selective and substantially effective than other biological 
agents. IL-23 inhibitors maintained a satisfactory safety profile with 
the most frequently reported adverse events being upper respiratory 
tract infections. The significant clinical efficacy of these agents in the 
treatment of psoriasis has paved the way for their evaluation in other 
immune-mediated diseases such as psoriatic arthritis, pityriasis rubra 
pilaris, atopic dermatitis or alopecia areata. However, larger randomized 
clinical trials and observational studies are needed to confirm effective-
ness of IL-23 inhibitors in these indications.
ProBiotiCS aS a SuPPlement in aCne vulgariS 
treatment
Natalia Komorniak, Dominika Pokrywka, Joanna Palma, 
Joanna Hołowko, Maja Czerwińska-Rogowska, Ewa Stachowska
Pomorski Uniwersytet Medyczny w Szczecinie
trustee of the paper: Ewa Stachowska
Acne vulgaris is a common disease in adolescents; however, the overall 
rates appear to be on the rise, especially among adults. The psycholo-
gical sequelae in acne patients include high rates of clinical depres-
sion, anxiety and anger. The mental health impairment scores among 
acne patients are higher than in those with many other chronic, non-
-psychiatric medical conditions, including epilepsy and diabetes. The 
pathophysiology of acne involves excess sebum production, follicular 
hyperkeratinisation and inflammation. These factors may be aggravated 
by stress. Furthermore, stress can alter the intestinal lining by encoura-
ging bacterial overgrowth and thereby compromising the intestinal 
barrier. The composition of intestinal microflora may also be disrupted 
by antibiotics therapies commonly used in acne. Probiotics are live 
microorganism with beneficial effects on the host when administered 
in adequate amounts. Probiotics have been widely studied because of 
their effects on the gastrointestinal tract and digestive functions, but 
these live microbes have wider applicability as evidenced by the gut-
-brain-skin axis theory. The potential benefit of probiotics includes the 
reduction of inflammation in acne. This is probably caused by the down-
-regulation of gene expression related to the release of inflammatory 
cytokines and the recruitment of pathogenic CD8 T cells while activating 
regulatory T cells. Probiotics can also decrease sebum content leading to 
lower follicular colonization by Propionibacterium acnes and decreased 
inflammation. Probiotics may also be considered as an adjunct for acne 
vulgaris treatment by providing a synergistic anti-inflammatory effect 
with systemic antibiotics while also reducing potential adverse events 
secondary to chronic antibiotic use.
oral propranolol for the treatment of 
infantile hemangiomaS 
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trustee of the paper: Mariusz Sikora 
Infantile hemangiomas are the most common benign tumor of infancy, 
occurring in approximately 5% to 10% of infants. Despite their benign 
and self-limited nature, some hemangiomas can cause complications 
such as obstruction, ulceration or disfigurement. In 2014 the US Food 
and Drug Administration approved propranolol hydrochloride oral so-
lution for the treatment of proliferating infantile hemangioma requiring 
systemic therapy. Overview of available methods clearly indicates that 
oral propranolol, a non-selective beta blocker, is the first-line treat-
ment. Propranolol induces the regression of infantile hemangiomas via 
vasoconstriction, decreased expression of growth factors and trigge-
ring of apoptosis. The standard dose reported in majority of studies is 
2−3 mg/kg/day. Therapy should be started at a dose of 1.0 mg/kg/day 
in two or three divided doses with feeds. The dose is then gradually 
increased. It is recommended to monitor heart rate and blood pressure 
before, one and two hours after the initial dose and later after every dose 
increase. Treatment typically ranges between 6 to 12 months, but may be 
longer, depending upon the initial treatment response, size and location 
of the hemangioma. Serious adverse effects (hypotension, bradycardia, 
hyperkalemia, bronchospasm, hypoglycemia) are infrequent. 
The most common reported side effects are reversible and include bron-
chitis, sleep disorders, diarrhea and cold extremities. Reports of successful 
treatment of hemangiomas with systemic propranolol led to the investiga-
tion of topical beta-adrenergic receptors antagonists in the therapy of in-
fantile hemangiomas. However, data on their safety and efficacy are limited.
wounD DeBriDement metHoDeS 
Dorota Mehrholz, Adrianna Opalska, Marcela Nowak,  
Wioletta Barańska-Rybak 
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trustee of the paper: Wioletta Barańska-Rybak 
Healing chronic wounds is a long-lasting and expensive process. Effec-
tive and proper debridement is a key element that promotes healing. Is 
presented various debridement techniques accepted by European Wo-
und Management Association and described the non-invasive methods 
applied in patients of Dermatology, Venerology and Allergology Clinic of 
Medical University of Gdansk. The basic, though not recommended, and 
ineffective method is dressing the wounds with the “dry on wet”; method. 
A treatment method that can be used in outpatient settings is purification 
using a Volkmann spoon. Alternative for bone spoon is monofilaments, 
that is a specially constructed cloth. The most invasive and costly methods 
include: hydroknife, an ultrasonic cleansing of the wound and surgical 
debridement. There are also special dressings available, which basic 
function is to dissolve and rinse the necrotic component of the wound. 
Those include cleansing and rinsing dressings, alginates, hydrofibers and 
collagenase in the form of an ointment. The most effective method is larval 
therapy. The described methods differ in their effectiveness, ease of use 
and price. For those reasons they should be selected individually for the 
specific type of the wound, the applicability and price.
woman’S dermatology 
Justyna Grabanowska-Jaroszewicz, Kinga Szczepanik, Zuzanna Kudas, 
Michał Czaplejewski
Studenckie Koło Naukowe Historii Medycyny, Warszawski Uniwersytet Medyczny
trustee of the paper: Ewa Skrzypek
This study deals with unconventional usage of eponyms in dermatology. 
The eponym is a term or concept which may be derived not only from 
a proper name or a person, but also from an animal or an item. 
The main study was inspired by references to renowned women der-
matologists and the attributes of femininity. The women chosen have 
not only made a name for themselves in dermatology, but also spread 
the image of a savant woman.
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A perfect example can be the eponym associated with the name of Maria 
Dąbska. The Dąbska tumour is one of the two skin tumours to be named 
after this outstanding Polish pathologist. Another woman to be distin-
guished in this way was Lilane Schnitzler, the first professor of dermatology 
in France, whose name is linked to the original description of the urticarial 
rash and monoclonal gammopathy syndrome. Next to be remembered is 
Madge Macklin, an outstanding social activist and geneticist whose name 
came to be associated with one of the varieties of ichthyosis hystrix. The 
next worth of mentioning is Sister Mary Joseph Dempsey who despite the 
lack of medical education was able to notice the connection between the 
peri-umbilical tumour and intra-abdominal malignancy.
Among eponyms referring to attributes of femininity we can mention 
woolly hair, shoulder-pad sign, Moroccan leather, papular-purpuric 
gloves and socks syndrome and gaiter region.
what’S new in prurituS’ treatment? Short report from 
the 9th world conference on itch
Dominika Ragin, Magdalena Basałygo, Katarzyna Nowacka,  
Barbara Zegarska
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Mikołaja Kopernika w Toruniu
trustee of the paper: Barbara Zegarska
Itch is the most common symptom in dermatology. It is a type of 
superficial cutaneous sensation, provoking the need to scratch. There 
are two types of itch, depending on its duration: acute (lasting up to 
6 weeks) and chronic (longer than 6 weeks). It can occur with or wi-
thout skin changes. New research project into antipruritic treatments 
are being conducted. The clinical trial on CD26 glycoprotein and its 
dipeptidyl peptidase IV (DPPIV) showed the possible role in the mana-
gement of itch in case of psoriasis and atopic dermatitis. There are also 
new conclusions on ciguatoxins (CTXs), which are preponderantly 
responsible for severe pruritus and allodynia. Most recent results of 
the research into the influence of the type A botulinum toxin (BoNT/A) 
on itch relief were also presented. In two-phase two clinical trials 
serlopitant showed statistically significant decrease in itch severity 
in patients with nodular prurigo and chronic pruritus. Research on 
dermocosmetic antipruritic spray, including Skin relief™ technology 
associated to enoxolone, confirmed the interest to use the product in 
chronic skin diseases, such as atopic dermatitis, psoriasis and chronic 
urticaria. Short-term pruritus is an essential defense mechanism for 
the organism. However, prolonged itch is an undesirable phenomenon 
and requires symptomatic treatment. Many clinical trials on the new 
substances for various types of itch are being conducted in study 
centers all over the world. Reduction of pruritus plays an important 
role in increasing quality of life in a variety of psychodermatological 
conditions.
